医療関係者向け　業績紹介

業績一覧

2022

論文・依頼原稿

Up-regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapy.

Miyazaki Y, Goto T, Li X, Nakayama K, Okasho K, Takeda M, Mizuno K, Kimura H, Uegaki M, Sumiyoshi T, Teramoto Y, Akamatsu S, Kobayashi T, Ogawa O, Inoue T.
Cancer Med. 2023 Feb;12(3):3328-3342. doi: 10.1002/cam4.5134. Epub 2022 Aug 13. PMID: 36812122

Identification of the α2 chain of interleukin-13 receptor as a potential biomarker for predicting castration resistance of prostate cancer using patient-derived xenograft models.

Nagai T, Terada N, Fujii M, Nagata Y, Nakahara K, Mukai S, Okasho K, Kamiyama Y, Akamatsu S, Kobayashi T, Iida K, Denawa M, Hagiwara M, Inoue T, Ogawa O, Kamoto T.
Cancer Rep (Hoboken). 2023 Feb;6(2):e1701. doi: 10.1002/cnr2.1701. Epub 2022 Aug 9. PMID: 36806727

ATM suppresses c-Myc overexpression in the mammary epithelium in response to estrogen.

Najnin RA, Al Mahmud MR, Rahman MM, Takeda S, Sasanuma H, Tanaka H, Murakawa Y, Shimizu N, Akter S, Takagi M, Sunada T, Akamatsu S, He G, Itou J, Toi M, Miyaji M, Tsutsui KM, Keeney S, Yamada S.
Cell Rep. 2023 Jan 31;42(1):111909. doi: 10.1016/j.celrep.2022.111909. Epub 2022 Dec 30. PMID: 36640339

Ten-year outcomes of whole-pelvic intensity-modulated radiation therapy for prostate cancer with regional lymph node metastasis.

Nakamura K, Norihisa Y, Ikeda I, Inokuchi H, Aizawa R, Kamoto T, Kamba T, Inoue T, Yamasaki T, Akamatsu S, Kobayashi T, Ogawa O, Mizowaki T.
Cancer Med. 2023 Apr;12(7):7859-7867. doi: 10.1002/cam4.5554. Epub 2022 Dec 19. PMID: 36536528

qShot MALDI analysis: A rapid, simple, convenient, and reliable quantitative phospholipidomics approach using MALDI-TOF/MS.

Nakayama K, Li X, Shimizu K, Akamatsu S, Inoue T, Kobayashi T, Ogawa O, Goto T.
Talanta. 2023 Mar 1;254:124099. doi: 10.1016/j.talanta.2022.124099. Epub 2022 Nov 28. PMID: 36502612

Real-world outcomes of pembrolizumab for platinum-refractory advanced urothelial carcinoma: Efficacy, safety, and evidence for trial-unfit patients.

Ito K, Kita Y, Kobayashi T.
Int J Urol. 2022 Dec 9. doi: 10.1111/iju.15101. Online ahead of print. PMID: 36482843

C-reactive protein as a prognostic predictor for non-muscle invasive bladder cancer after intravesical bacillus Calmette-Guérin therapy: A Japan Urological Oncology Group study analysis.

Nishikawa R, Miyake M, Morizane S, Shimizu R, Teraoka S, Honda M, Iida K, Nishimura N, Sazuka T, Kimura T, Ito A, Shiga K, Taoka R, Kojima T, Kobayashi T, Nishiyama N, Kitamura H, Nishiyama H, Fujimoto K, Takenaka A.
Int J Urol. 2023 Mar;30(3):299-307. doi: 10.1111/iju.15106. Epub 2022 Nov 30. PMID: 36448522

The efficacy of sequential therapy with docetaxel and cabazitaxel for castration-resistant prostate cancer: A retrospective multi-institutional study in Japan.

Terada N, Sawada A, Kawanishi H, Fujimoto T, Magaribuchi T, Chihara I, Hashimoto K, Sakurai T, Shimizu Y, Uegaki M, Nakashima M, Narita S, Kubota M, Yamada Y, Tohi Y, Okabe K, Yatsuda J, Kamoto T.
Int J Urol. 2023 Feb;30(2):227-234. doi: 10.1111/iju.15097. Epub 2022 Nov 14. PMID: 36375045

Retroperitoneal malignant extra-gastrointestinal neuroectodermal tumor with EWSR1::CREM fusion and IL-6-related systemic inflammatory symptoms: a case report.

Sugimoto A, Yoshizawa A, Yoshida A, Kono J, Sawada A, Fujimoto M, Minamiguchi S, Kobayashi T, Haga H.
Virchows Arch. 2022 Nov 1. doi: 10.1007/s00428-022-03442-0. Online ahead of print. PMID: 36318291

Bmal1 Regulates Prostate Growth via Cell-Cycle Modulation.

Ueda M, Kono J, Sengiku A, Nagumo Y, Mathis BJ, Shimba S, Taketo MM, Kobayashi T, Ogawa O, Negoro H.
Int J Mol Sci. 2022 Sep 24;23(19):11272. doi: 10.3390/ijms231911272. PMID: 36232573

Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)-a prospective single-arm interventional study.

Sugimoto M, Kato T, Tohi Y, Shimizu Y, Matsumoto R, Inoue T, Takezawa Y, Masui K, Sasaki H, Hirama H, Saito S, Egawa S, Kamoto T, Teramukai S, Kojima S, Kikuchi T, Kakehi Y.
BMC Urol. 2022 Sep 14;22(1):151. doi: 10.1186/s12894-022-01096-3. PMID: 36104667

Association of financial toxicity with quality of life in testicular cancer survivors.

Nezu K, Yamashita S, Kakimoto K, Uemura M, Kishida T, Kawai K, Nakamura T, Goto T, Osawa T, Nishimura K, Nonomura N, Negoro H, Shiraishi T, Ukimura O, Ogawa O, Shinohara N, Suzukamo Y, Ito A, Arai Y.
Int J Urol. 2022 Dec;29(12):1526-1534. doi: 10.1111/iju.15039. Epub 2022 Sep 14. PMID: 36102302

Prevalence and risk estimation of cancer-predisposing genes for upper urinary tract urothelial carcinoma in Japanese.

Sekine Y, Iwasaki Y, Hakozaki N, Endo M, Kamatani Y, Matsuda K, Murakami Y, Sano T, Akamatsu S, Kobayashi T, Nakagawa H, Numakura K, Narita S, Habuchi T, Momozawa Y.
Jpn J Clin Oncol. 2022 Dec 5;52(12):1441-1445. doi: 10.1093/jjco/hyac141. PMID: 36093724

Paraurachal paraganglioma.

Tsuruta M, Goto T, Kono J, Kita Y, Masui K, Sano T, Fujimoto M, Sawada A, Akamatsu S, Kobayashi T.
IJU Case Rep. 2022 May 31;5(5):358-361. doi: 10.1002/iju5.12488. eCollection 2022 Sep. PMID: 36090947

Limited predictive impact of tumor size dynamics on further tumor shrinkage after 4 cycles of first-line chemotherapy in patients with advanced urothelial carcinoma.

Hamada A, Sano T, Kita Y, Takada H, Sakatani T, Nakamura K, Ito K, Goto T, Sawada A, Akamatsu S, Kobayashi T.
Urol Oncol.2022 Dec;40(12):540.e1-540.e10. doi: 10.1016/j.urolonc.2022.07.008. Epub 2022 Aug 23. PMID: 36008256

Combined laparoscopic and transperineal total pelvic exenteration for recurrent rectal cancer-a video vignette.

Kawada K, Hanada K, Yokoyama D, Akamatsu S, Goto T, Obama K.
Colorectal Dis. 2023 Feb;25(2):333-334. doi: 10.1111/codi.16308. Epub 2022 Sep 4. PMID: 36000801

Immune-related adverse events in urothelial cancer patients: Adjustment for immortal time bias.

Otsuka H, Kita Y, Ito K, Sano T, Inokuchi J, Tomida R, Takahashi A, Matsumoto K, Kurahashi R, Ozaki Y, Uegaki M, Maruyama S, Mukai S, Tsutsumi M, Kawahara T, Segawa T, Kitamura H, Morita S, Kobayashi T.
Cancer Sci. 2022 Nov;113(11):3912-3921. doi: 10.1111/cas.15539. Epub 2022 Sep 2. PMID: 35997546

Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancer.

Kimura H, Mizuno K, Shiota M, Narita S, Terada N, Fujimoto N, Ogura K, Hatano S, Iwasaki Y, Hakozaki N, Ishitoya S, Sumiyoshi T, Goto T, Kobayashi T, Nakagawa H, Kamoto T, Eto M, Habuchi T, Ogawa O, Momozawa Y, Akamatsu S.
Br J Cancer. 2022 Nov;127(9):1680-1690. doi: 10.1038/s41416-022-01915-2. Epub 2022 Aug 19. PMID: 35986085

Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study.

Uemura H, Kobayashi K, Yokomizo A, Hinotsu S, Horie S, Kakehi Y, Nonomura N, Ogawa O, Oya M, Suzuki K, Saito A, Asakawa K, Uno S, Naito S.
Int J Clin Oncol. 2022 Oct;27(10):1632-1643. doi: 10.1007/s10147-022-02221-w. Epub 2022 Aug 10. PMID: 35948732

Androgen receptor mutations for precision medicine in prostate cancer.

Shiota M, Akamatsu S, Tsukahara S, Nagakawa S, Matsumoto T, Eto M.
Endocr Relat Cancer. 2022 Aug 17;29(10):R143-R155. doi: 10.1530/ERC-22-0140. Print 2022 Oct 1. PMID: 35900853

Case Report: A Case of Renal Cell Carcinoma Unclassified With Medullary Phenotype Exhibiting a Favorable Response to Combined Immune Checkpoint Blockade.

Takeda M, Kashima S, Fuchigami Y, Yoshino T, Kataoka TR, Yamasaki T, Kagamu H, Kobayashi T, Akamatsu S.
Front Immunol. 2022 Jul 5;13:934991. doi: 10.3389/fimmu.2022.934991. eCollection 2022. PMID: 35865543

Discontinuation of pembrolizumab for advanced urothelial carcinoma without disease progression: Nationwide cohort study.

Ito K, Kita Y, Yokomizo A, Miki J, Yoshio Y, Matsumoto H, Segawa T, Karashima T, Nishiyama N, Imai K, Suekane S, Nagasawa S, Higashi S, Nishiyama H, Kitamura H, Kobayashi T.
Cancer Med. 2023 Feb;12(3):2325-2332. doi: 10.1002/cam4.5057. Epub 2022 Jul 21. PMID: 35864744

Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer.

Murakami Y, Matsumoto K, Miyake M, Amano N, Shimura S, Nishimura N, Iida K, Matsushita Y, Abe T, Yamada T, Uemura M, Matsui Y, Taoka R, Kojima T, Kobayashi T, Nishiyama N, Kitamura H, Nishiyama H, Fujimoto K, Iwamura M.
Int J Urol. 2022 Oct;29(10):1195-1203. doi: 10.1111/iju.14976. Epub 2022 Jul 20. PMID: 35858755

Tumor Lysis Syndrome in a Patient with Germ Cell Tumor : A Case Report.

Koterazawa S, Masui K, Hama Y, Takahashi Y, Sawada A, Akamatsu S, Kobayashi T.
Hinyokika Kiyo. 2022 Jun;68(6):201-205. doi: 10.14989/ActaUrolJap_68_6_201. PMID: 35850510

A Retrospective Study of Lymph Node Dissection for Renal Cell Carcinoma.

Suzuki R, Goto T, Yoshino T, Sawada A, Akamatsu S, Saito R, Kobayashi T, Yamasaki T, Inoue T, Kamba T, Ogawa O.
Hinyokika Kiyo. 2022 Jun;68(6):165-170. doi: 10.14989/ActaUrolJap_68_6_165. PMID: 35850504

Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab.

Takahashi S, Narita S, Fujiyama N, Hatakeyama S, Kobayashi T, Kato R, Naito S, Sakatani T, Kashima S, Koizumi A, Yamamoto R, Nara T, Kanda S, Numakura K, Saito M, Obara W, Tsuchiya N, Ohyama C, Ogawa O, Habuchi T.
Cancer Sci. 2022 Dec;113(12):4059-4069. doi: 10.1111/cas.15488. Epub 2022 Sep 24. PMID: 35848083

Incomplete sagittal septum of the bladder with cystolithiasis.

Fujimoto T, Goto T, Kanematsu A, Nishimatsu H, Fujimoto M, Matsuoka T, Kono J, Kita Y, Masui K, Sano T, Sawada A, Akamatsu S, Kobayashi T.
IJU Case Rep. 2022 Apr 30;5(4):264-267. doi: 10.1002/iju5.12451. eCollection 2022 Jul. PMID: 35795107

Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls.

Sekine Y, Iwasaki Y, Aoi T, Endo M, Hirata M, Kamatani Y, Matsuda K, Sugano K, Yoshida T, Murakami Y, Fukui T, Akamatsu S, Ogawa O, Nakagawa H, Numakura K, Narita S, Habuchi T, Momozawa Y.
Hum Mol Genet. 2022 Jun 22;31(12):1962-1969. doi: 10.1093/hmg/ddab345. PMID: 35764097

Association of Increased Age With Decreased Response to Intravesical Instillation of Bacille Calmette-Guérin in Patients With High-Risk Non-Muscle Invasive Bladder Cancer: Retrospective Multi-Institute Results From the Japanese Urological Oncology Research Group JUOG-UC-1901-BCG.

Inoue T, Miyake M, Nishimura N, Onozawa M, Kashima S, Numakura K, Narita S, Iida K, Uemura M, Matsushita Y, Inokuchi J, Matsui Y, Taoka R, Kojima T, Kobayashi T, Nishiyama N, Kitamura H, Nishiyama H, Fujimoto K, Habuchi T.
Urology. 2022 Sep;167:158-164. doi: 10.1016/j.urology.2022.05.034. Epub 2022 Jun 11. PMID: 35700751

A novel missense mutation in the folliculin gene associated with the renal tumor-only phenotype of Birt-Hogg-Dubé syndrome.

Sano T, Fukui T, Makita N, Shimizu K, Kono J, Masui K, Sato T, Goto T, Sawada A, Fujimoto M, Kojima F, Torishima M, Wada T, Furuya M, Ogawa O, Kobayashi T, Akamatsu S.
Cancer Genet. 2022 Aug;266-267:28-32. doi: 10.1016/j.cancergen.2022.06.001. Epub 2022 Jun 5. PMID: 35691222

Cell Lines of Circulating Tumor Cells: What Is Known and What Needs to Be Resolved.

Shimada Y, Sudo T, Akamatsu S, Sunada T, Myomoto A, Okano K, Shimizu K.
J Pers Med. 2022 Apr 21;12(5):666. doi: 10.3390/jpm12050666. PMID: 35629089

Diagnostic Accuracy of Transperineal MRI-Ultrasound Fusion Biopsy at the Introduction Period.

Hattori Y, Kono J, Yoshino T, Masui K, Sato T, Kashima S, Sano T, Goto T, Sawada A, Akamatsu S, Kobayashi T, Inoue T, Ogawa O.
Hinyokika Kiyo. 2022 Apr;68(4):99-105. doi: 10.14989/ActaUrolJap_68_4_99. PMID: 35613897

Real-world treatment patterns and clinical outcomes of Japanese patients with non-muscle invasive bladder cancer receiving intravesical bacillus Calmette-Guérin treatment.

Miyake M, Kikuchi E, Shinozaki K, Piao Y, Hayashi N, Koto R, Jinushi M, Kobayashi T.
Int J Urol. 2022 Oct;29(10):1120-1129. doi: 10.1111/iju.14933. Epub 2022 May 21. PMID: 35598101

Rapidly Progressive Bladder Cancer Diagnosed because of Spontaneous Bladder Rupture.

Hagimoto H, Sano T, Kashima S, Yoshino T, Goto T, Sawada A, Akamatsu S, Yamasaki T, Fujimoto M, Kajita Y, Kobayashi T, Ogawa O.
Case Rep Urol. 2022 May 9;2022:4586199. doi: 10.1155/2022/4586199. eCollection 2022. PMID: 35585958

Robotic supralevator total pelvic exenteration with lateral pelvic sidewall dissection for rectal cancer.

Kawada K, Okada T, Masui K, Nishizaki D, Kasahara K, Yokoyama D, Obama K.
Tech Coloproctol. 2022 Sep;26(9):761-762. doi: 10.1007/s10151-022-02625-w. Epub 2022 May 16. PMID: 35576084

Flavonoid Nobiletin Attenuates Cyclophosphamide-Induced Cystitis in Mice through Mechanisms That Involve Inhibition of IL-1β Induced Connexin 43 Upregulation and Gap Junction Communication in Urothelial Cells.

Kono J, Ueda M, Sengiku A, Suadicani SO, Woo JT, Kobayashi T, Ogawa O, Negoro H.
Int J Mol Sci. 2022 May 1;23(9):5037. doi: 10.3390/ijms23095037. PMID: 35563427

Tolerability and treatment outcome of pembrolizumab in patients with advanced urothelial carcinoma and severe renal dysfunction.

Kita Y, Ito K, Kanda S, Joraku A, Yamaguchi R, Shimizu Y, Hayata N, Somiya S, Shibasaki N, Kimura T, Hikami K, Yamada T, Abe T, Tsuchihashi K, Tatarano S, Nishiyama H, Kitamura H, Kobayashi T.
Urol Oncol. 2022 Sep;40(9):410.e11-410.e18. doi: 10.1016/j.urolonc.2022.04.005. Epub 2022 May 9. PMID: 35551861

Machine learning diagnosis by immunoglobulin N-glycan signatures for precision diagnosis of urological diseases.

Iwamura H, Mizuno K, Akamatsu S, Hatakeyama S, Tobisawa Y, Narita S, Narita T, Yamashita S, Kawamura S, Sakurai T, Fujita N, Kodama H, Noro D, Kakizaki I, Nakaji S, Itoh K, Tsuchiya N, Ito A, Habuchi T, Ohyama C, Yoneyama T.
Cancer Sci. 2022 Jul;113(7):2434-2445. doi: 10.1111/cas.15395. Epub 2022 May 25. PMID: 35524940

Clinical significance of IDC-P as predictive factor after intensity-modulated radiation therapy.

Aizawa R, Tsuzuki T, Haga H, Nakamura K, Ogata T, Inoue T, Kobayashi T, Akamatsu S, Goto T, Ogawa O, Mizowaki T.
Cancer Sci. 2022 Jul;113(7):2425-2433. doi: 10.1111/cas.15392. Epub 2022 May 19. PMID: 35514196

A case of microsatellite instability-high clinically advanced castration-resistant prostate cancer showing a remarkable response to pembrolizumab sustained over at least 18 months.

Shimizu K, Sano T, Mizuno K, Sunada T, Makita N, Hagimoto H, Goto T, Sawada A, Fujimoto M, Ichioka K, Ogawa O, Kobayashi T, Akamatsu S.
Cold Spring Harb Mol Case Stud. 2022 Jun 22;8(4):a006194. doi: 10.1101/mcs.a006194. Print 2022 Jun. PMID: 35487690

Radiotherapy plus androgen deprivation therapy for prostate-specific antigen persistence in lymph node-positive prostate cancer.

Shiota M, Takamatsu D, Kimura T, Tashiro K, Matsui Y, Tomida R, Saito R, Tsutsumi M, Yokomizo A, Yamamoto Y, Edamura K, Miyake M, Morizane S, Yoshino T, Matsukawa A, Narita S, Matsumoto R, Kasahara T, Hashimoto K, Matsumoto H, Kato M, Akamatsu S, Joraku A, Kato M, Yamaguchi T, Saito T, Kaneko T, Takahashi A, Kato T, Sakamoto S, Enokida H, Kanno H, Terada N, Suekane S, Nishiyama N, Eto M, Kitamura H; Japanese Urological Oncology Group.
Cancer Sci. 2022 Jul;113(7):2386-2396. doi: 10.1111/cas.15383. Epub 2022 May 17. PMID: 35485635

Editorial Comment from Dr Kobayashi to Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma.

Kobayashi T.
Int J Urol. 2022 Jul;29(7):739. doi: 10.1111/iju.14919. Epub 2022 Apr 27. PMID: 35478200

Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration-resistant prostate cancer: AFTERCAB study.

Uemura H, Kobayashi K, Yokomizo A, Hinotsu S, Horie S, Kakehi Y, Naito S, Nonomura N, Ogawa O, Oya M, Suzuki K, Saito A, Uno S, Akaza H.
BJUI Compass. 2021 Aug 20;3(1):26-36. doi: 10.1002/bco2.103. eCollection 2022 Jan. PMID: 35475157

Clinical and molecular correlates of response to immune checkpoint blockade in urothelial carcinoma with liver metastasis.

Yoshida T, Ohe C, Ito K, Takada H, Saito R, Kita Y, Sano T, Tsuta K, Kinoshita H, Kitamura H, Nishiyama H, Kobayashi T; Japan Urological Oncology Group.
Cancer Immunol Immunother. 2022 Nov;71(11):2815-2828. doi: 10.1007/s00262-022-03204-6. Epub 2022 Apr 20. PMID: 35445305

Robot-assisted partial nephrectomy for renal cell carcinoma in the isthmus of horseshoe kidney.

Sawada A, Kono J, Hattori Y, Goto T, Akamatsu S, Kobayashi T.
Urol Case Rep. 2022 Apr 3;43:102076. doi: 10.1016/j.eucr.2022.102076. eCollection 2022 Jul. PMID: 35400118

Development and validation of prediction model for incident overactive bladder: The Nagahama study.

Funada S, Luo Y, Yoshioka T, Setoh K, Tabara Y, Negoro H, Yoshimura K, Matsuda F, Efthimiou O, Ogawa O, Furukawa TA, Kobayashi T, Akamatsu S.
Int J Urol. 2022 Jul;29(7):748-756. doi: 10.1111/iju.14887. Epub 2022 Apr 7. PMID: 35393696

Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1.

Makino Y, Kamiyama Y, Brown JB, Tanaka T, Murakami R, Teramoto Y, Goto T, Akamatsu S, Terada N, Inoue T, Kodama T, Ogawa O, Kobayashi T.
Commun Biol. 2022 Apr 1;5(1):299. doi: 10.1038/s42003-022-03227-w. PMID: 35365763

Clinical practice pattern in patients with advanced urothelial cancer who had progressed on pembrolizumab in the pre-enfortumab vedotin era.

Kita Y, Ito K, Sano T, Hashimoto K, Mochizuki T, Shiraishi Y, Araki H, Fujiwara M, Kanamaru S, Takahashi T, Hishiki K, Okada T, Ogawa K, Ito M, Kojima T, Nishiyama N, Matsui Y, Nishiyama H, Kitamura H, Kobayashi T.
Int J Urol. 2022 Jul;29(7):647-655. doi: 10.1111/iju.14861. Epub 2022 Mar 18. PMID: 35304776

Olaparib in patients with mCRPC with homologous recombination repair gene alterations: PROfound Asian subset analysis.

Matsubara N, Nishimura K, Kawakami S, Joung JY, Uemura H, Goto T, Kwon TG, Sugimoto M, Kato M, Wang SS, Pang ST, Chen CH, Fujita T, Nii M, Shen L, Dujka M, Hussain M, de Bono J.
Jpn J Clin Oncol. 2022 May 5;52(5):441-448. doi: 10.1093/jjco/hyac015. PMID: 35229141

A case of skin rash during oral administration of a novel androgen receptor inhibitor, darolutamide.

Shima K, Nomura T, Yamada Y, Kobayashi T, Kabashima K.
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e554-e557. doi: 10.1111/jdv.18023. Epub 2022 Mar 2. PMID: 35184345

Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data.

Tomida R, Miyake M, Minato R, Sawada Y, Matsumura M, Iida K, Hori S, Fukui S, Ohyama C, Miyake H, Hongo F, Taoka R, Kobayashi T, Kojima T, Matsui Y, Nishiyama N, Kitamura H, Nishiyama H, Fujimoto K, Hashine K; Japanese Urological Oncology Group.
Int J Clin Oncol. 2022 May;27(5):958-968. doi: 10.1007/s10147-022-02127-7. Epub 2022 Feb 10. PMID: 35142962

A rare case of intestinal lymphangiectasia induced by pazopanib.

Masui K, Hama Y, Sawada A, Akamatsu S, Sakaue J, Okabe M, Kobayashi T.
Int Cancer Conf J. 2021 Dec 1;11(1):87-90. doi: 10.1007/s13691-021-00527-6. eCollection 2022 Jan. PMID: 35127325

Intensity-modulated radiation therapy for prostate cancer after rectal surgery: a single hospital long-term safety analysis.

Zhang S, Nakamura K, Aizawa R, Akamatsu S, Mizowaki T.
Int J Clin Oncol. 2022 May;27(5):977-982. doi: 10.1007/s10147-022-02124-w. Epub 2022 Feb 5. PMID: 35122170

Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy.

Akamatsu S, Terada N, Takata R, Kinoshita H, Shimatani K, Momozawa Y, Yamamoto M, Tada H, Kawamorita N, Narita S, Kato T, Nitta M, Kandori S, Koike Y, Inazawa J, Kimura T, Kimura H, Kojima T, Terachi T, Sugimoto M, Habuchi T, Arai Y, Yamamoto S, Matsuda T, Obara W, Kamoto T, Inoue T, Nakagawa H, Ogawa O.
JNCI Cancer Spectr. 2022 Jan 9;6(1):pkac001. doi: 10.1093/jncics/pkac001. eCollection 2022 Feb. PMID: 35118230

Detection efficacy of PET/CT with 18F-FSU-880 in patients with suspected recurrent prostate cancer: a prospective single-center study.

Otani T, Saga T, Ishimori T, Kidera E, Shimizu Y, Aizawa R, Nakamura K, Goto T, Akamatsu S, Mizowaki T, Nakamoto Y.
Ann Nucl Med. 2022 Mar;36(3):302-309. doi: 10.1007/s12149-021-01704-6. Epub 2022 Jan 22. PMID: 35064537

IFN-Gamma Expression in the Tumor Microenvironment and CD8-Positive Tumor-Infiltrating Lymphocytes as Prognostic Markers in Urothelial Cancer Patients Receiving Pembrolizumab.

Sakatani T, Kita Y, Fujimoto M, Sano T, Hamada A, Nakamura K, Takada H, Goto T, Sawada A, Akamatsu S, Kobayashi T.
Cancers (Basel). 2022 Jan 6;14(2):263. doi: 10.3390/cancers14020263. PMID: 35053427

STAT3 Polymorphism Associates With mTOR Inhibitor-Induced Interstitial Lung Disease in Patients With Renal Cell Carcinoma.

Yamamoto K, Ioroi T, Shinomiya K, Yoshida A, Harada K, Fujisawa M, Omura T, Ikemi Y, Nakagawa S, Yonezawa A, Ogawa O, Matsubara K, Iwamoto T, Nishikawa K, Hayashi S, Tohara D, Murakami Y, Motoshima T, Jono H, Yano I.
Oncol Res. 2022 May 4;29(1):11-23. doi: 10.3727/096504022X16418911579334. Epub 2022 Jan 11. PMID: 35016744

Proteolysis of a histone acetyl reader, ATAD2, induces chemoresistance of cancer cells under severe hypoxia by inhibiting cell cycle progression in S phase.

Haitani T, Kobayashi M, Koyasu S, Akamatsu S, Suwa T, Onodera Y, Nam JM, Nguyen PTL, Menju T, Date H, Ogawa O, Harada H.
Cancer Lett. 2022 Mar 1;528:76-84. doi: 10.1016/j.canlet.2021.12.028. Epub 2021 Dec 29. PMID: 34973392

Prognostication in Japanese patients with bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer undergoing early radical cystectomy.

Nishimura N, Miyake M, Iida K, Miyamoto T, Tomida R, Numakura K, Inokuchi J, Yoneyama T, Matsumura Y, Yajima S, Masuda H, Terada N, Taoka R, Kobayashi T, Kojima T, Matsui Y, Nishiyama N, Kitamura H, Nishiyama H, Fujimoto K.
Int J Urol. 2022 Mar;29(3):242-249. doi: 10.1111/iju.14759. Epub 2021 Dec 13. PMID: 34902876

Editorial Comment to Management of major venous bleeding during minimally invasive pelvic surgery: A proposed protocol for "What should we do next?".

Kobayashi T.
Int J Urol. 2022 Feb;29(2):179. doi: 10.1111/iju.14736. Epub 2021 Nov 2. PMID: 34729820

Maculopapular-type drug eruptions caused by apalutamide: case series and a review of the literature.

Shima K, Nomura T, Yamada Y, Usui S, Kobayashi T, Kabashima K.
J Eur Acad Dermatol Venereol. 2022 Feb;36(2):e113-e115. doi: 10.1111/jdv.17657. Epub 2021 Sep 23. PMID: 34510570

Impact of prior intravesical bacillus Calmette-Guerin therapy on the effectiveness of pembrolizumab for patients with metastatic urothelial carcinoma.

Taoka R, Kobayashi T, Hidaka Y, Abe H, Ito K, Kojima T, Kato M, Kanda S, Hatakeyama S, Matsui Y, Matsushita Y, Naito S, Shiga M, Miyake M, Muro Y, Nakanishi S, Kato Y, Shibuya T, Hayashi T, Yasumoto H, Yoshida T, Uemura M, Kamiyama M, Morita S, Ogawa O, Nishiyama H, Kitamura H, Sugimoto M; Japan Urological Oncology Group.
Urol Oncol. 2022 Mar;40(3):107.e1-107.e9. doi: 10.1016/j.urolonc.2021.08.002. Epub 2021 Aug 26. PMID: 34454824

Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPAN.

Kato T, Hirama H, Mitsuzuka K, Maruyama S, Sasaki H, Saito T, Matsumoto R, Sakamoto S, Sakai Y, Fukuhara H, Naya Y, Tsukino H, Hara I, Ogawa O, Hashine K, Fumimasa F, Yokomizo A, Tohi Y, Kakehi Y, Sugimoto M.
Prostate Cancer Prostatic Dis. 2022 Apr;25(4):666-671. doi: 10.1038/s41391-021-00422-4. Epub 2021 Jul 12. PMID: 34253849

Efficacy and safety of pembrolizumab for older patients with chemoresistant urothelial carcinoma assessed using propensity score matching.

Nishiyama N, Kobayashi T, Narita S, Hidaka Y, Ito K, Maruyama S, Mukai S, Tsutsumi M, Miki J, Okuno T, Yoshio Y, Matsumoto H, Shimazui T, Segawa T, Karashima T, Masui K, Fukuta F, Tashiro K, Imai K, Suekane S, Nagasawa S, Higashi S, Fukui T, Kojima T, Morita S, Ogawa O, Nishiyama H, Kitamura H; Japan Urological Oncology Group.
J Geriatr Oncol. 2022 Jan;13(1):88-93. doi: 10.1016/j.jgo.2021.07.002. Epub 2021 Jul 6. PMID: 34238726

Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR.

Kobayashi T, Ito K, Kojima T, Maruyama S, Mukai S, Tsutsumi M, Miki J, Okuno T, Yoshio Y, Matsumoto H, Shimazui T, Segawa T, Karashima T, Masui K, Fukuta F, Tashiro K, Imai K, Suekane S, Nagasawa S, Higashi S, Fukui T, Ogawa O, Kitamura H, Nishiyama H.
Cancer Immunol Immunother. 2022 Feb;71(2):461-471. doi: 10.1007/s00262-021-03000-8. Epub 2021 Jul 7. PMID: 34235546

Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis.

Kobayashi M, Narita S, Matsui Y, Kanda S, Hidaka Y, Abe H, Tsuzuki T, Ito K, Kojima T, Kato M, Hatakeyama S, Matsushita Y, Naito S, Shiga M, Miyake M, Muro Y, Nakanishi S, Kato Y, Shibuya T, Hayashi T, Yasumoto H, Yoshida T, Uemura M, Taoka R, Kamiyama M, Morita S, Habuchi T, Ogawa O, Nishiyama H, Kitamura H, Kobayashi T; Japan Urological Oncology Group.
BJU Int. 2022 Aug;130(2):226-234. doi: 10.1111/bju.15510. Epub 2021 Jul 6. PMID: 34110696

2021

論文・依頼原稿

Clinical Impact of Detecting Low-Frequency Variants in Cell-Free DNA on Treatment of Castration-Resistant Prostate Cancer.

Mizuno K, Sumiyoshi T, Okegawa T, Terada N, Ishitoya S, Miyazaki Y, Kojima T, Katayama H, Fujimoto N, Hatakeyama S, Shiota M, Yoshimura K, Matsui Y, Narita S, Matsumoto H, Kurahashi R, Kanno H, Ito K, Kimura H, Kamiyama Y, Sunada T, Goto T, Kobayashi T, Yamada H, Tsuchiya N, Kamba T, Matsuyama H, Habuchi T, Eto M, Ohyama C, Ito A, Nishiyama H, Okuno H, Kamoto T, Fujimoto A, Ogawa O, Akamatsu S.
Clin Cancer Res. 2021 Nov 15;27(22):6164-6173. doi: 10.1158/1078-0432.CCR-21-2328. Epub 2021 Sep 15. PMID: 34526361.

B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity.

Zhang B, Vogelzang A, Miyajima M, Sugiura Y, Wu Y, Chamoto K, Nakano R, Hatae R, Menzies RJ, Sonomura K, Hojo N, Ogawa T, Kobayashi W, Tsutsui Y, Yamamoto S, Maruya M, Narushima S, Suzuki K, Sugiya H, Murakami K, Hashimoto M, Ueno H, Kobayashi T, Ito K, Hirano T, Shiroguchi K, Matsuda F, Suematsu M, Honjo T, Fagarasan S.
Nature. 2021 Nov;599(7885):471-476. doi: 10.1038/s41586-021-04082-1. Epub 2021 Nov 3. PMID: 34732892; PMCID: PMC8599023.

Clinical practice pattern in patients with advanced urothelial cancer who had progressed on pembrolizumab in the pre-enfortumab vedotin era.

Kita Y, Ito K, Sano T, Hashimoto K, Mochizuki T, Shiraishi Y, Araki H, Fujiwara M, Kanamaru S, Takahashi T, Hishiki K, Okada T, Ogawa K, Ito M, Kojima T, Nishiyama N, Matsui Y, Nishiyama H, Kitamura H, Kobayashi T.
Int J Urol. 2022 Mar 18. doi: 10.1111/iju.14861. Epub ahead of print. PMID: 35304776.

IFN-Gamma Expression in the Tumor Microenvironment and CD8-Positive Tumor-Infiltrating Lymphocytes as Prognostic Markers in Urothelial Cancer Patients Receiving Pembrolizumab.

Sakatani T, Kita Y, Fujimoto M, Sano T, Hamada A, Nakamura K, Takada H, Goto T, Sawada A, Akamatsu S, Kobayashi T.
Cancers (Basel). 2022 Jan 6;14(2):263. doi: 10.3390/cancers14020263. PMID: 35053427; PMCID: PMC8774131.

Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR.

Kobayashi T, Ito K, Kojima T, Maruyama S, Mukai S, Tsutsumi M, Miki J, Okuno T, Yoshio Y, Matsumoto H, Shimazui T, Segawa T, Karashima T, Masui K, Fukuta F, Tashiro K, Imai K, Suekane S, Nagasawa S, Higashi S, Fukui T, Ogawa O, Kitamura H, Nishiyama H.
Cancer Immunol Immunother. 2022 Feb;71(2):461-471. doi: 10.1007/s00262-021-03000-8. Epub 2021 Jul 7. PMID: 34235546.

Detection of von Hippel-Lindau gene mutation in circulating cell-free DNA for clear cell renal cell carcinoma.

Sumiyoshi T, Yamasaki T, Takeda M, Mizuno K, Utsunomiya N, Sakamoto H, Nakamura E, Ogawa O, Akamatsu S.
Cancer Sci. 2021 Aug;112(8):3363-3374. doi: 10.1111/cas.14972. Epub 2021 Jun 16. PMID: 34009695; PMCID: PMC8353948.

Impact of the objective response to and number of cycles of platinum-based first-line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumab.

Kato M, Kobayashi T, Matsui Y, Ito K, Hikami K, Yamada T, Ogawa K, Nakamura K, Sassa N, Yokomizo A, Abe T, Tsuchihashi K, Tatarano S, Inokuchi J, Tomida R, Fujiwara M, Takahashi A, Matsumoto K, Shimizu K, Araki H, Kurahashi R, Ozaki Y, Tashiro Y, Uegaki M, Kojima T, Uchida J, Ogawa O, Nishiyama H, Kitamura H; Japan Urological Oncology Group.
Int J Urol. 2021 Dec;28(12):1261-1267. doi: 10.1111/iju.14686. Epub 2021 Sep 20. PMID: 34545627.

Impact of prior intravesical bacillus Calmette-Guerin therapy on the effectiveness of pembrolizumab for patients with metastatic urothelial carcinoma.

Taoka R, Kobayashi T, Hidaka Y, Abe H, Ito K, Kojima T, Kato M, Kanda S, Hatakeyama S, Matsui Y, Matsushita Y, Naito S, Shiga M, Miyake M, Muro Y, Nakanishi S, Kato Y, Shibuya T, Hayashi T, Yasumoto H, Yoshida T, Uemura M, Kamiyama M, Morita S, Ogawa O, Nishiyama H, Kitamura H, Sugimoto M; Japan Urological Oncology Group.
Urol Oncol. 2022 Mar;40(3):107.e1-107.e9. doi: 10.1016/j.urolonc.2021.08.002. Epub 2021 Aug 26. PMID: 34454824.

Modification of Platinum-based Systemic Chemotherapy for Advanced Urothelial Carcinoma in Patients With Suboptimal Renal Function.

Hamada A, Sano T, Matsumoto K, Sakatani T, Nakamura K, Sawada A, Akamatsu S, Matsui Y, Ogawa O, Kobayashi T.
In Vivo. 2021 Sep-Oct;35(5):2821-2829. doi: 10.21873/invivo.12569. PMID: 34410974; PMCID: PMC8408732.

Long-term safety of high-dose whole pelvic IMRT for high-risk localized prostate cancer through 10-year follow-up.

Aizawa R, Nakamura K, Norihisa Y, Ogata T, Inoue T, Yamasaki T, Kobayashi T, Akamatsu S, Ogawa O, Mizowaki T.
Int J Clin Oncol. 2021 Nov;26(11):2113-2122. doi: 10.1007/s10147-021-02002-x. Epub 2021 Aug 2. PMID: 34338920.

High level of phosphatidylcholines/lysophosphatidylcholine ratio in urine is associated with prostate cancer.

Li X, Nakayama K, Goto T, Kimura H, Akamatsu S, Hayashi Y, Fujita K, Kobayashi T, Shimizu K, Nonomura N, Ogawa O, Inoue T.
Cancer Sci. 2021 Oct;112(10):4292-4302. doi: 10.1111/cas.15093. Epub 2021 Aug 19. PMID: 34328656; PMCID: PMC8486217.

Efficacy and safety of pembrolizumab for older patients with chemoresistant urothelial carcinoma assessed using propensity score matching.

Nishiyama N, Kobayashi T, Narita S, Hidaka Y, Ito K, Maruyama S, Mukai S, Tsutsumi M, Miki J, Okuno T, Yoshio Y, Matsumoto H, Shimazui T, Segawa T, Karashima T, Masui K, Fukuta F, Tashiro K, Imai K, Suekane S, Nagasawa S, Higashi S, Fukui T, Kojima T, Morita S, Ogawa O, Nishiyama H, Kitamura H; Japan Urological Oncology Group.
J Geriatr Oncol. 2022 Jan;13(1):88-93. doi: 10.1016/j.jgo.2021.07.002. Epub 2021 Jul 6. PMID: 34238726.

Extrapolation of physiologically based pharmacokinetic model for tacrolimus from renal to liver transplant patients.

Itohara K, Yano I, Nakagawa S, Yonezawa A, Omura T, Imai S, Nakagawa T, Sawada A, Kobayashi T, Tochio A, Sakai K, Taura K, Ogawa O, Matsubara K.
Drug Metab Pharmacokinet. 2022 Feb;42:100423. doi: 10.1016/j.dmpk.2021.100423. Epub 2021 Oct 1. PMID: 34896748.

Antitumor effect of WEE1 blockade as monotherapy or in combination with cisplatin in urothelial cancer.

Murakami K, Kita Y, Sakatani T, Hamada A, Mizuno K, Nakamura K, Takada H, Matsumoto K, Sano T, Goto T, Akamatsu S, Saito R, Tsuruyama T, Ogawa O, Kobayashi T.
Cancer Sci. 2021 Sep;112(9):3669-3681. doi: 10.1111/cas.15051. Epub 2021 Jul 29. PMID: 34212455; PMCID: PMC8409401.

Establishment and characterization of a novel treatment-related neuroendocrine prostate cancer cell line KUCaP13.

Okasho K, Mizuno K, Fukui T, Lin YY, Kamiyama Y, Sunada T, Li X, Kimura H, Sumiyoshi T, Goto T, Kobayashi T, Lin D, Wang Y, Collins CC, Inoue T, Ogawa O, Akamatsu S.
Cancer Sci. 2021 Jul;112(7):2781-2791. doi: 10.1111/cas.14935. Epub 2021 Jun 1. PMID: 33960594; PMCID: PMC8253279.

Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort.

Ito K, Kobayashi T, Kojima T, Hikami K, Yamada T, Ogawa K, Nakamura K, Sassa N, Yokomizo A, Abe T, Tsuchihashi K, Tatarano S, Inokuchi J, Tomida R, Fujiwara M, Takahashi A, Matsumoto K, Shimizu K, Araki H, Kurahashi R, Osaki Y, Tashiro Y, Uegaki M, Ogawa O, Kitamura H, Nishiyama H.
Cancer Med. 2021 May;10(10):3188-3196. doi: 10.1002/cam4.3863. Epub 2021 May 1. PMID: 33931987; PMCID: PMC8124127.

[Complete Remission of Metastatic Renal Cell Carcinoma with Invasion of the Duodenum and Pancreas after Treatment with Nivolumab Plus Ipilimumab Followed by Axitinib and Surgery : A Case Report].

Hagimoto H, Yamazaki T, Kashima S, Yoshino T, Goto T, Sano T, Sawada A, Akamatsu S, Kobayashi T, Nakano K, Yagi S, Matsuoka Y, Fujimoto M, Kitamura T, Ogawa O.
Hinyokika Kiyo. 2021 May;67(5):197-203. Japanese. doi: 10.14989/ActaUrolJap_67_5_197. PMID: 34126663.

Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis.

Kobayashi M, Narita S, Matsui Y, Kanda S, Hidaka Y, Abe H, Tsuzuki T, Ito K, Kojima T, Kato M, Hatakeyama S, Matsushita Y, Naito S, Shiga M, Miyake M, Muro Y, Nakanishi S, Kato Y, Shibuya T, Hayashi T, Yasumoto H, Yoshida T, Uemura M, Taoka R, Kamiyama M, Morita S, Habuchi T, Ogawa O, Nishiyama H, Kitamura H, Kobayashi T; Japan Urological Oncology Group.
BJU Int. 2021 Jun 10. doi: 10.1111/bju.15510. Epub ahead of print. PMID: 34110696.

[A Case of Pelvic Unicentric Castleman Disease Treated by Preoperative Transcatheter Arterial Embolization and Tumor Complete Resection with Combined Lower Abdominal and Posterior Approach].

Suzuki R, Goto T, Banno H, Fuchigami Y, Hattahara K, Hida T, Fujiwara M, Yoshino T, Kita Y, Sawada A, Akamatsu S, Saito R, Kobayashi T, Yamazaki T, Inoue T, Shimizu H, Kurata M, Maeda H, Okamoto T, Toguchida J, Ogawa O.
Hinyokika Kiyo. 2021 Apr;67(4):157-162. Japanese. doi: 10.14989/ActaUrolJap_67_4_157. PMID: 34107612.

[Promotion of Diversity in the Academic Field of Urology : Analysis of 10,000 Articles Published in Acta Urologica Japonica during a 65-Year Period].

Kobayashi T, Tamura H, Hiragi S, Nishida S, Miyagawa M, Kuroda T, Ogawa O.
Hinyokika Kiyo. 2021 Apr;67(4):125-132. Japanese. doi: 10.14989/ActaUrolJap_67_4_125. PMID: 34107607.

A narrative review of urinary phospholipids: from biochemical aspect towards clinical application.

Li X, Nakayama K, Goto T, Akamatsu S, Kobayashi T, Shimizu K, Ogawa O, Inoue T.
Transl Androl Urol. 2021 Apr;10(4):1829-1849. doi: 10.21037/tau-20-1263. PMID: 33968673; PMCID: PMC8100843.

Long-term clinical outcomes of external beam radiation therapy for oligometastatic prostate cancer: A combination of prostate-targeted treatment and metastasis-directed therapy.

Aizawa R, Takayama K, Nakamura K, Ogata T, Inoue T, Yamasaki T, Kobayashi T, Akamatsu S, Tashiro Y, Ota H, Ogawa O, Mizowaki T.
Int J Urol. 2021 Jul;28(7):749-755. doi: 10.1111/iju.14567. Epub 2021 Apr 2. PMID: 33811409.

Effect of optimal neoadjuvant chemotherapy on oncological outcomes of locally advanced bladder cancer with laparoscopic radical cystectomy: A matched-pair analysis in a multicenter cohort.

Kubota M, Kanno T, Inoue T, Yamasaki T, Okumura K, Ito K, Yamada H, Fujii M, Shimizu Y, Yatsuda J, Moroi S, Shichiri Y, Akao T, Sawada A, Saito R, Kobayashi T, Kawakita M, Ogawa O.
Int J Urol. 2021 Jun;28(6):656-664. doi: 10.1111/iju.14533. Epub 2021 Mar 7. PMID: 33682243.

Evaluation of the Quality of Life and Health-Related Quality of Life of Patients With End-Stage Kidney Disease Resulting From Kidney Transplantation Using the Kidney Disease Quality of Life-Short Form and EuroQOL-5 Dimension-5 Level Questionnaires.

Sawada A, Hiragi S, Tamura H, Goto R, Matsuyama Y, Sakai K, Miyata H, Yanagita M, Kuroda T, Ogawa O, Kobayashi T.
Transplant Proc. 2021 Apr;53(3):881-884. doi: 10.1016/j.transproceed.2020.09.018. Epub 2020 Dec 7. PMID: 33303208.

Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy.

Akamatsu S, Terada N, Takata R, Kinoshita H, Shimatani K, Momozawa Y, Yamamoto M, Tada H, Kawamorita N, Narita S, Kato T, Nitta M, Kandori S, Koike Y, Inazawa J, Kimura T, Kimura H, Kojima T, Terachi T, Sugimoto M, Habuchi T, Arai Y, Yamamoto S, Matsuda T, Obara W, Kamoto T, Inoue T, Nakagawa H, Ogawa O.
JNCI Cancer Spectr. 2022 Jan 9;6(1):pkac001. doi: 10.1093/jncics/pkac001. PMID: 35118230; PMCID: PMC8807580.

Narrative review of challenges in the management of advanced neuroendocrine prostate cancer.

Okasho K, Ogawa O, Akamatsu S.
Transl Androl Urol. 2021 Oct;10(10):3953-3962. doi: 10.21037/tau-20-1131. PMID: 34804838; PMCID: PMC8575589.

SPINK1 as a plasma marker for tumor hypoxia and a therapeutic target for radiosensitization.

Suwa T, Kobayashi M, Shirai Y, Nam JM, Tabuchi Y, Takeda N, Akamatsu S, Ogawa O, Mizowaki T, Hammond EM, Harada H.
JCI Insight. 2021 Nov 8;6(21):e148135. doi: 10.1172/jci.insight.148135. PMID: 34747365; PMCID: PMC8663551.

Protocol for development and validation of a prediction model for 5-year risk of incident overactive bladder in the general population: the Nagahama study.

Funada S, Luo Y, Yoshioka T, Setoh K, Tabara Y, Negoro H, Akamatsu S, Yoshimura K, Matsuda F, Furukawa TA, Efthimiou O, Ogawa O.
BMC Urol. 2021 May 13;21(1):78. doi: 10.1186/s12894-021-00848-x. PMID: 33985490; PMCID: PMC8120704.

The association between missense polymorphisms in SRD5A2 and HSD3B1 and treatment failure with abiraterone for castration-resistant prostate cancer.

Shiota M, Akamatsu S, Narita S, Sumiyoshi T, Fujiwara M, Uchiumi T, Ogawa O, Habuchi T, Eto M.
Pharmacogenomics J. 2021 Aug;21(4):440-445. doi: 10.1038/s41397-021-00220-0. Epub 2021 Mar 1. PMID: 33649516.

A rare case of intestinal lymphangiectasia induced by pazopanib.

Masui K, Hama Y, Sawada A, Akamatsu S, Sakaue J, Okabe M, Kobayashi T.
Int Cancer Conf J. 2021 Dec 1;11(1):87-90. doi: 10.1007/s13691-021-00527-6. PMID: 35127325; PMCID: PMC8786988.

2020

論文・依頼原稿

Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases.

Ishigaki K, Akiyama M, Kanai M, Takahashi A, Kawakami E, Sugishita H, Sakaue S, Matoba N, Low SK, Okada Y, Terao C, Amariuta T, Gazal S, Kochi Y, Horikoshi M, Suzuki K, Ito K, Koyama S, Ozaki K, Niida S, Sakata Y, Sakata Y, Kohno T, Shiraishi K, Momozawa Y, Hirata M, Matsuda K, Ikeda M, Iwata N, Ikegawa S, Kou I, Tanaka T, Nakagawa H, Suzuki A, Hirota T, Tamari M, Chayama K, Miki D, Mori M, Nagayama S, Daigo Y, Miki Y, Katagiri T, Ogawa O, Obara W, Ito H, Yoshida T, Imoto I, Takahashi T, Tanikawa C, Suzuki T, Sinozaki N, Minami S, Yamaguchi H, Asai S, Takahashi Y, Yamaji K, Takahashi K, Fujioka T, Takata R, Yanai H, Masumoto A, Koretsune Y, Kutsumi H, Higashiyama M, Murayama S, Minegishi N, Suzuki K, Tanno K, Shimizu A, Yamaji T, Iwasaki M, Sawada N, Uemura H, Tanaka K, Naito M, Sasaki M, Wakai K, Tsugane S, Yamamoto M, Yamamoto K, Murakami Y, Nakamura Y, Raychaudhuri S, Inazawa J, Yamauchi T, Kadowaki T, Kubo M, Kamatani Y.
Nat Genet. 2020 Jul;52(7):669-679. doi: 10.1038/s41588-020-0640-3. Epub 2020 Jun 8. PMID: 32514122; PMCID: PMC7968075.

Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab.

Kobayashi T, Ito K, Kojima T, Kato M, Kanda S, Hatakeyama S, Matsui Y, Matsushita Y, Naito S, Shiga M, Miyake M, Muro Y, Nakanishi S, Kato Y, Shibuya T, Hayashi T, Yasumoto H, Yoshida T, Uemura M, Taoka R, Kamiyama M, Ogawa O, Kitamura H, Nishiyama H; Japan Urological Oncology Group.
Cancer Sci. 2021 Feb;112(2):760-773. doi: 10.1111/cas.14762. Epub 2020 Dec 21. PMID: 33283385; PMCID: PMC7893997.

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.

Powles T, van der Heijden MS, Castellano D, Galsky MD, Loriot Y, Petrylak DP, Ogawa O, Park SH, Lee JL, De Giorgi U, Bögemann M, Bamias A, Eigl BJ, Gurney H, Mukherjee SD, Fradet Y, Skoneczna I, Tsiatas M, Novikov A, Suárez C, Fay AP, Duran I, Necchi A, Wildsmith S, He P, Angra N, Gupta AK, Levin W, Bellmunt J; DANUBE study investigators.
Lancet Oncol. 2020 Dec;21(12):1574-1588. doi: 10.1016/S1470-2045(20)30541-6. Epub 2020 Sep 21. Erratum in: Lancet Oncol. 2021 Jan;22(1):e5. PMID: 32971005.

Impact of Nocturia on Mortality: The Nagahama Study.

Funada S, Tabara Y, Setoh K, Negoro H, Akamatsu S, Yoshino T, Yoshimura K, Watanabe N, Furukawa TA, Matsuda F, Ogawa O.
J Urol. 2020 Nov;204(5):996-1002. doi: 10.1097/JU.0000000000001138. Epub 2020 May 12. PMID: 32396408.

Successful surgical management of recurrent urachal adenocarcinoma: A case report.

Somiya S, Aoyama A, Yamasaki T, Inoue T, Ogawa O, Kobayashi T.
Urol Case Rep. 2020 Apr 13;32:101196. doi: 10.1016/j.eucr.2020.101196. PMID: 32322529; PMCID: PMC7171456.

Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology.

Saito R, Kobayashi T, Kashima S, Matsumoto K, Ogawa O.
Int J Clin Oncol. 2020 May;25(5):831-841. doi: 10.1007/s10147-019-01520-z. Epub 2019 Aug 12. PMID: 31407168.

99mTc-mercaptoacetyltriglycine Cortical Renography Predicts Outcomes in Adult Living Donor Renal Transplant Recipients.

Kobayashi T, Nakamoto Y, Sunada T, Sawada A, Yamasaki T, Ogawa O.
Transplant Proc. 2020 Dec;52(10):3090-3096. doi: 10.1016/j.transproceed.2020.02.169. Epub 2020 Jun 27. PMID: 32605777.

Barriers for sperm cryopreservation in advanced germ cell tumor patients: a 20-year experience.

Ito K, Ichioka K, Dahal S, Matsui Y, Nakayama T, Hatayama H, Ogawa O, Negoro H.
Int J Clin Oncol. 2020 May;25(5):906-911. doi: 10.1007/s10147-019-01607-7. Epub 2020 Jan 1. PMID: 31894434.

Solitary recurrence of prostate cancer surrounded by seminal vesicle/vas deferens-like epithelium.

Takamori H, Kamba T, Sumiyoshi S, Tsuzuki T, Kashima S, Yoshino T, Sano T, Goto T, Sawada A, Akamatsu S, Kobayashi T, Yamasaki T, Mizowaki T, Ogawa O, Inoue T.
IJU Case Rep. 2020 Jul 30;3(5):171-173. doi: 10.1002/iju5.12168. PMID: 32914063; PMCID: PMC7469812.

Enhancement of transduction efficiency using Adeno-associated viral vectors by chemical pretreatment to mice bladder urothelium.

Hamada A, Kita Y, Murakami K, Matsumoto K, Sakatani T, Sano T, Ogawa O, Kobayashi T.
J Virol Methods. 2020 May;279:113854. doi: 10.1016/j.jviromet.2020.113854. Epub 2020 Mar 18. PMID: 32198026.

Rapid semen identification from mixed body fluids using methylation-sensitive high-resolution melting analysis of the DACT1 gene.

Fujimoto S, Hamano Y, Ichioka K, Manabe S, Hirai E, Ogawa O, Tamaki K.
Leg Med (Tokyo). 2021 Feb;48:101806. doi: 10.1016/j.legalmed.2020.101806. Epub 2020 Nov 4. PMID: 33189063.

Three-dimensional simulation analysis of microdissection testicular sperm extraction for patients with non-obstructive azoospermia.

Ichioka K, Matsui Y, Terada N, Negoro H, Goto T, Ogawa O.
Andrology. 2020 Sep;8(5):1214-1221. doi: 10.1111/andr.12812. Epub 2020 May 18. PMID: 32374923; PMCID: PMC7522677.

Cytotoxic T Lymphocytes Regenerated from iPS Cells Have Therapeutic Efficacy in a Patient-Derived Xenograft Solid Tumor Model.

Kashima S, Maeda T, Masuda K, Nagano S, Inoue T, Takeda M, Kono Y, Kobayashi T, Saito S, Higuchi T, Ichise H, Kobayashi Y, Iwaisako K, Terada K, Agata Y, Numakura K, Saito M, Narita S, Yasukawa M, Ogawa O, Habuchi T, Kawamoto H.
iScience. 2020 Apr 24;23(4):100998. doi: 10.1016/j.isci.2020.100998. Epub 2020 Apr 6. PMID: 32259478; PMCID: PMC7188741.

Developmental stages of tertiary lymphoid tissue reflect local injury and inflammation in mouse and human kidneys.

Sato Y, Boor P, Fukuma S, Klinkhammer BM, Haga H, Ogawa O, Floege J, Yanagita M.
Kidney Int. 2020 Aug;98(2):448-463. doi: 10.1016/j.kint.2020.02.023. Epub 2020 May 28. PMID: 32473779.

Cognitive behavioral therapy for overactive bladder in women: study protocol for a randomized controlled trial.

Funada S, Watanabe N, Goto T, Negoro H, Akamatsu S, Ueno K, Uozumi R, Ichioka K, Segawa T, Akechi T, Furukawa TA, Ogawa O.
BMC Urol. 2020 Aug 20;20(1):129. doi: 10.1186/s12894-020-00697-0. PMID: 32819331; PMCID: PMC7439638.

Clinical Practice Guidelines for Bladder Cancer 2019 edition by the Japanese Urological Association: Revision working position paper.

Matsumoto H, Shiraishi K, Azuma H, Inoue K, Uemura H, Eto M, Ohyama C, Ogawa O, Kikuchi E, Kitamura H, Shinohara N, Takahashi S, Tsuzuki T, Nakagawa M, Narumi Y, Nishiyama H, Habuchi T, Hinotsu S, Fujii Y, Fujimoto K, Fujimoto H, Mizowaki T, Matsuyama H.
Int J Urol. 2020 May;27(5):362-368. doi: 10.1111/iju.14210. Epub 2020 Mar 14. PMID: 32172529.

Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort.

Kanno T, Inoue T, Ito K, Okumura K, Yamada H, Kawakita M, Fujii M, Shimizu Y, Yatsuda J, Moroi S, Shichiri Y, Akao T, Sawada A, Kobayashi T, Ogawa O.
Int J Urol. 2020 Mar;27(3):250-256. doi: 10.1111/iju.14182. Epub 2020 Jan 16. PMID: 31944410.

Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision.

Matsumoto H, Shiraishi K, Azuma H, Inoue K, Uemura H, Eto M, Ohyama C, Ogawa O, Kikuchi E, Kitamura H, Shinohara N, Takahashi S, Tsuzuki T, Nakagawa M, Narumi Y, Nishiyama H, Habuchi T, Hinotsu S, Fujii Y, Fujimoto K, Fujimoto H, Mizowaki T, Matsuyama H.
Int J Urol. 2020 Sep;27(9):702-709. doi: 10.1111/iju.14281. Epub 2020 Jun 21. PMID: 32564429.

A Case of Primary Ewing Sarcoma of the Kidney Treated with Multidisciplinary Approach.

Imai K, Yamasaki T, Sakamoto H, Nakamura K, Mizowaki T, Ogawa O, Aoyama T.
Hinyokika Kiyo. 2020 Sep;66(9):297-302. Japanese. doi: 10.14989/ActaUrolJap_66_9_297. PMID: 32988166.

Trp53 Mutation in Keratin 5 (Krt5)-Expressing Basal Cells Facilitates the Development of Basal Squamous-Like Invasive Bladder Cancer in the Chemical Carcinogenesis of Mouse Bladder.

Masuda N, Murakami K, Kita Y, Hamada A, Kamada M, Teramoto Y, Sakatani T, Matsumoto K, Sano T, Saito R, Okuno Y, Ogawa O, Kobayashi T.
Am J Pathol. 2020 Aug;190(8):1752-1762. doi: 10.1016/j.ajpath.2020.04.005. Epub 2020 Apr 24. PMID: 32339497.

Evaluation of the Quality of Life and Health-Related Quality of Life of Patients With End-Stage Kidney Disease Resulting From Kidney Transplantation Using the Kidney Disease Quality of Life-Short Form and EuroQOL-5 Dimension-5 Level Questionnaires.

Sawada A, Hiragi S, Tamura H, Goto R, Matsuyama Y, Sakai K, Miyata H, Yanagita M, Kuroda T, Ogawa O, Kobayashi T.
Transplant Proc. 2021 Apr;53(3):881-884. doi: 10.1016/j.transproceed.2020.09.018. Epub 2020 Dec 7. PMID: 33303208.

Medical history of nocturnal enuresis during school age is an independent risk factor for nocturia in adults: The Nagahama study.

Negoro H, Fukunaga A, Setoh K, Kawaguchi T, Funada S, Yoshino T, Tabara Y, Yoshimura K, Kanematsu A, Nishiyama H, Matsuda F, Ogawa O; Nagahama Study Group.
Neurourol Urodyn. 2021 Jan;40(1):326-333. doi: 10.1002/nau.24562. Epub 2020 Oct 29. PMID: 33118643.

Increased risk of disease progression in younger men: Analysis of factors predicting biochemical failure and castration-resistant prostate cancer after high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer.

Aizawa R, Takayama K, Nakamura K, Inoue T, Yamasaki T, Kobayashi T, Akamatsu S, Ogawa O, Mizowaki T.
Urol Oncol. 2021 Feb;39(2):131.e9-131.e15. doi: 10.1016/j.urolonc.2020.09.026. Epub 2020 Oct 27. PMID: 33127301.

Clinical feasibility and acceptability of adding cognitive behavioral therapy to pharmacotherapy for drug-resistant overactive bladder in women: A single-arm pilot study.

Funada S, Watanabe N, Goto T, Negoro H, Akamatsu S, Uozumi R, Kishimoto S, Ichioka K, Segawa T, Furukawa TA, Ogawa O.
Low Urin Tract Symptoms. 2021 Jan;13(1):69-78. doi: 10.1111/luts.12333. Epub 2020 Jul 3. PMID: 32618414.

Perioperative and oncological outcomes of laparoscopic radical cystectomy with intracorporeal versus extracorporeal ileal conduit: A matched-pair comparison in a multicenter cohort in Japan.

Kanno T, Inoue T, Kawakita M, Ito K, Okumura K, Yamada H, Kubota M, Fujii M, Shimizu Y, Yatsuda J, Kobori G, Moroi S, Shichiri Y, Akao T, Sawada A, Saito R, Kobayashi T, Ogawa O.
Int J Urol. 2020 Jun;27(6):559-565. doi: 10.1111/iju.14245. Epub 2020 Apr 20. PMID: 32314467.

Development and external validation of a preoperative nomogram for predicting pathological locally advanced disease of clinically localized upper urinary tract carcinoma.

Yoshida T, Kobayashi T, Kawaura T, Miyake M, Ito K, Okuno H, Murota T, Makita N, Kawakita M, Kawa G, Kitawaki T, Fujimoto K, Matsuyama H, Shiina H, Azuma H, Ogawa O, Kinoshita H, Matsuda T.
Cancer Med. 2020 Jun;9(11):3733-3741. doi: 10.1002/cam4.2988. Epub 2020 Apr 6. PMID: 32253820; PMCID: PMC7286474.

Long-term clinical outcomes of salvage pelvic radiation therapy for oligo-recurrent pelvic lymph nodes after definitive external-beam radiation therapy for non-metastatic prostate cancer.

Sato GE, Aizawa R, Nakamura K, Takayama K, Inoue T, Yamasaki T, Kobayashi T, Akamatsu S, Ogawa O, Mizowaki T.
J Radiat Res. 2020 Jul 6;61(4):622-628. doi: 10.1093/jrr/rraa044. PMID: 32583860; PMCID: PMC7336814.

Validation study of the Japanese version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Testicular Cancer 26 for patients with testicular cancer.

Yamashita S, Suzukamo Y, Kakimoto K, Uemura M, Kishida T, Kawai K, Nakamura T, Goto T, Osawa T, Yamada S, Nishimura K, Nonomura N, Nishiyama H, Shiraishi T, Ukimura O, Ogawa O, Shinohara N, Ito A, Arai Y.
Int J Urol. 2021 Feb;28(2):176-182. doi: 10.1111/iju.14422. Epub 2020 Nov 10. PMID: 33174259.

LacdiNAc-Glycosylated Prostate-specific Antigen Density is a Potential Biomarker of Prostate Cancer.

Inoue T, Kaneko T, Muramatsu S, Kimura H, Yoshino T, Goto T, Sawada A, Akamatsu S, Kobayashi T, Yamasaki T, Kaya T, Ogawa O.
Clin Genitourin Cancer. 2020 Feb;18(1):e28-e36. doi: 10.1016/j.clgc.2019.10.011. Epub 2019 Oct 17. PMID: 31711843.

Masked acute rejection of the graft kidney under the recovery of native kidneys in a patient who underwent simultaneous liver and kidney transplantation.

Hattahara K, Sawada A, Sakai K, Teramoto Y, Nakamoto Y, Okajima H, Yamasaki T, Inoue T, Ogawa O, Kobayashi T.
IJU Case Rep. 2020 Aug 18;3(6):237-240. doi: 10.1002/iju5.12197. PMID: 33163913; PMCID: PMC7609179.

Longitudinal Analysis of Bidirectional Relationships between Nocturia and Depressive Symptoms: The Nagahama Study.

Funada S, Tabara Y, Negoro H, Akamatsu S, Yoshino T, Yoshimura K, Watanabe N, A Furukawa T, Matsuda F, Ogawa O.
J Urol. 2020 May;203(5):984-990. doi: 10.1097/JU.0000000000000683. Epub 2019 Nov 21. PMID: 31750764.

Functional and genomic characterization of patient-derived xenograft model to study the adaptation to mTORC1 inhibitor in clear cell renal cell carcinoma.

Sakamoto H, Yamasaki T, Sumiyoshi T, Takeda M, Shibasaki N, Utsunomiya N, Arakaki R, Akamatsu S, Kobayashi T, Inoue T, Kamba T, Nakamura E, Ogawa O.
Cancer Med. 2021 Jan;10(1):119-134. doi: 10.1002/cam4.3578. Epub 2020 Oct 27. PMID: 33107222; PMCID: PMC7826464.

Detectability of prostate cancer in different parts of the gland with 3-Tesla multiparametric magnetic resonance imaging: correlation with whole-mount histopathology.

Ito K, Furuta A, Kido A, Teramoto Y, Akamatsu S, Terada N, Yamasaki T, Inoue T, Ogawa O, Kobayashi T.
Int J Clin Oncol. 2020 Apr;25(4):732-740. doi: 10.1007/s10147-019-01587-8. Epub 2019 Dec 2. PMID: 31792635.

Add-on effects of tadalafil in tamsulosin-treated patients with small benign prostatic enlargement: A randomized, placebo-controlled, double-blind, crossover study.

Negoro H, Goto T, Akamatsu S, Terada N, Kobayashi T, Matsui Y, Yamamoto T, Omura T, Yonezawa A, Matsubara K, Ogawa O.
Neurourol Urodyn. 2020 Jan;39(1):237-242. doi: 10.1002/nau.24175. Epub 2019 Oct 2. PMID: 31578771.

Feasibility of laparoscopic adrenalectomy for metastatic adrenal tumors in selected patients: a retrospective multicenter study of Japanese populations.

Goto T, Inoue T, Kobayashi T, Yamasaki T, Ishitoya S, Segawa T, Ito N, Shichiri Y, Okumura K, Okuno H, Kawakita M, Kanaoka T, Terada N, Mukai S, Sugi M, Kinoshita H, Kamoto T, Matsuda T, Ogawa O.
Int J Clin Oncol. 2020 Jan;25(1):126-134. doi: 10.1007/s10147-019-01533-8. Epub 2019 Aug 30. PMID: 31471786.

Sequential Use of Androgen Receptor Axis-targeted Agents in Chemotherapy-naive Castration-resistant Prostate Cancer: A Multicenter Retrospective Analysis With 3-Year Follow-up.

Kobayashi T, Terada N, Kimura T, Matsubara N, Murakami K, Mori K, Fujimoto Y, Akamatsu S, Inoue T, Ogawa O.
Clin Genitourin Cancer. 2020 Feb;18(1):e46-e54. doi: 10.1016/j.clgc.2019.09.011. Epub 2019 Sep 26. PMID: 31759831.

A comparison of laparoendoscopic single-site surgery versus conventional procedures for laparoscopic donor nephrectomy: a Japanese multi-institutional retrospective study.

Inoue T, Miura M, Yanishi M, Furukawa J, Sato F, Nitta M, Yoshimura K, Hagiuda J, Shinoda K, Kobayashi T, Miyajima A, Nakagawa K, Oya M, Ogawa O, Mimata H, Kanayama HO, Fujisawa M, Terachi T, Matsuda T, Habuchi T; LESS and RPS Research Group in Japanese Society of Endourology.
Surg Endosc. 2020 Aug;34(8):3424-3434. doi: 10.1007/s00464-019-07119-9. Epub 2019 Sep 23. PMID: 31549237.

Low incidence of late recurrence in patients with intermediate-risk prostate cancer treated by intensity-modulated radiation therapy plus short-term androgen deprivation therapy.

Aizawa R, Takayama K, Nakamura K, Inoue T, Yamasaki T, Kobayashi T, Akamatsu S, Ogawa O, Mizowaki T.
Int J Clin Oncol. 2020 Apr;25(4):713-719. doi: 10.1007/s10147-019-01596-7. Epub 2019 Dec 9. PMID: 31820209.

Effect of neoadjuvant chemotherapy on health-related quality of life in patients with muscle-invasive bladder cancer: results from JCOG0209, a randomized phase III study.

Kitamura H, Hinotsu S, Tsukamoto T, Shibata T, Mizusawa J, Kobayashi T, Miyake M, Nishiyama N, Kojima T, Nishiyama H; Urologic Oncology Study Group of the Japan Clinical Oncology Group.
Jpn J Clin Oncol. 2020 Dec 16;50(12):1464-1469. doi: 10.1093/jjco/hyaa123. PMID: 32699909.

Patient-Derived Urothelial Cancer Xenograft Models: A Systematic Review and Future Perspectives.

Kita Y, Saito R, Inoue T, Kim W, Y., Ogawa O, Kobayashi T.
Bladder Cancer. 6(2):131-141, 2020.

Utility of ICG fluorescence imaging with vessel clamp for ileocecal resection while preserving ileal conduit constructed after previous total cystectomy.

Okada T, Kawada K, Kobayashi T, Wada T, Sakai Y.
Surg Case Rep. 2020 Oct 2;6(1):257. doi: 10.1186/s40792-020-01013-6. PMID: 33006721; PMCID: PMC7532243.

Combined robotic and cystoscopic surgery for rectal cancer invading urinary bladder.

Kawada K, Kobayashi T, Mizuno R, Goto S, Sakai Y.
Int Cancer Conf J. 2020 Apr 1;9(3):102-106. doi: 10.1007/s13691-020-00413-7. PMID: 32582511; PMCID: PMC7297884.

TDP2 suppresses genomic instability induced by androgens in the epithelial cells of prostate glands.

Al Mahmud MR, Ishii K, Bernal-Lozano C, Delgado-Sainz I, Toi M, Akamatsu S, Fukumoto M, Watanabe M, Takeda S, Cortés-Ledesma F, Sasanuma H.
Genes Cells. 2020 Jul;25(7):450-465. doi: 10.1111/gtc.12770. Epub 2020 May 5. PMID: 32277721; PMCID: PMC7497232.

Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer.

Kawai Y, Imada K, Akamatsu S, Zhang F, Seiler R, Hayashi T, Leong J, Beraldi E, Saxena N, Kretschmer A, Oo HZ, Contreras-Sanz A, Matsuyama H, Lin D, Fazli L, Collins CC, Wyatt AW, Black PC, Gleave ME.
Mol Cancer Ther. 2020 Oct;19(10):2210-2220. doi: 10.1158/1535-7163.MCT-19-1031. Epub 2020 Aug 26. PMID: 32847979.

2019

論文・依頼原稿

12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.

Takata R, Takahashi A, Fujita M, Momozawa Y, Saunders EJ, Yamada H, Maejima K, Nakano K, Nishida Y, Hishida A, Matsuo K, Wakai K, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Sasaki M, Shimizu A, Tanno K, Minegishi N, Suzuki K, Matsuda K, Kubo M, Inazawa J, Egawa S, Haiman CA, Ogawa O, Obara W, Kamatani Y, Akamatsu S, Nakagawa H.
Nat Commun. 2019 Sep 27;10(1):4422. doi: 10.1038/s41467-019-12267-6.

Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.

Kuroiwa K, Inokuchi J, Nishiyama H, Kojima T, Kakehi Y, Sugimoto M, Tanigawa T, Fujimoto H, Gotoh M, Masumori N, Ogawa O, Eto M, Ohyama C, Yokomizo A, Matsuyama H, Ichikawa T, Mizusawa J, Eba J, Naito S; JCOG UOSG.
J Urol. 2019 Dec;202(6):1127-1135. doi: 10.1097/JU.0000000000000422. Epub 2019 Jun 28.

Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate Cancer.

Akamatsu S, Kubota M, Uozumi R, Narita S, Takahashi M, Mitsuzuka K, Hatakeyama S, Sakurai T, Kawamura S, Ishidoya S, Hoshi S, Ishida M, Mizuno K, Ogura K, Goto T, Terada N, Kobayashi T, Yamasaki T, Inoue T, Tsuchiya N, Ohyama C, Arai Y, Habuchi T, Morita S, Ogawa O.
Eur Urol Oncol. 2019 May;2(3):320-328. doi: 10.1016/j.euo.2018.10.011. Epub 2018 Nov 23.

Analytical performance of a new automated chemiluminescent magnetic immunoassays for soluble PD-1, PD-L1, and CTLA-4 in human plasma.

Goto M, Chamoto K, Higuchi K, Yamashita S, Noda K, Iino T, Miura M, Yamasaki T, Ogawa O, Sonobe M, Date H, Hamanishi J, Mandai M, Tanaka Y, Chikuma S, Hatae R, Muto M, Minamiguchi S, Minato N, Honjo T.
Sci Rep. 2019 Jul 12;9(1):10144. doi: 10.1038/s41598-019-46548-3.

Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab.

Yamauchi I, Yasoda A, Matsumoto S, Sakamori Y, Kim Y. H, Nomura M, Otsuka A, Yamasaki T, Saito R, Kitamura M, Kitawaki T, Hishizawa M, Kawaguchi-Sakita N, Fujii T, Taura D, Sone M, Inagaki N.
PloS one 2019, 14 (5), e0216954.

eVIDENCE: a practical variant filtering for low-frequency variants detection in cell-free DNA.

Mizuno K, Akamatsu S, Sumiyoshi T, Wong JH, Fujita M, Maejima K, Nakano K, Ono A, Aikata H, Ueno M, Hayami S, Yamaue H, Chayama K, Inoue T, Ogawa O, Nakagawa H, Fujimoto A.
Sci Rep. 2019 Oct 22;9(1):15017. doi: 10.1038/s41598-019-51459-4.

RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review.

Kato I, Furuya M, Baba M, Kameda Y, Yasuda M, Nishimoto K, Oyama M, Yamasaki T, Ogawa O, Niino H, Nakaigawa N, Yano Y, Sakamoto K, Urata Y, Mikami K, Yamasaki S, Tanaka R, Takagi T, Kondo T, Nagashima Y.
Histopathology. 2019 Aug;75(2):254-265. doi: 10.1111/his.13866. Epub 2019 Jun 25.

[A Case of Late Onset Nivolumab-Induced Interstitial Nephritis in a Patient with Metastatic Renal Cell Carcinoma].

Hattahara K, Yamasaki T, Sawada A, Tanigaki K, Endo S, Teramoto Y, Banno H, Fuchigami Y, Suzuki R, Fujiwara M, Hida T, Yoshino T, Kita Y, Goto T, Akamatsu S, Saito R, Kobayashi T, Inoue T, Ogawa O.
Hinyokika Kiyo. 2019 May;65(5):157-161. doi: 10.14989/ActaUrolJap_65_5_157.

Efficacy and Safety of Carboplatin Plus Paclitaxel as the First-, Second-, and Third-line Chemotherapy in Men With Castration-resistant Prostate Cancer.

Fujiwara M, Akamatsu S, Sumiyoshi T, Segawa T, Mizuno K, Yoshino T, Goto T, Sawada A, Saito R, Kobayashi T, Yamasaki T, Inoue T, Ogawa O.
Clin Genitourin Cancer. 2019 Oct;17(5):e923-e929. doi: 10.1016/j.clgc.2019.04.017. Epub 2019 Jun 12.

TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer.

Kawahara T, Kojima T, Kandori S, Kurobe M, Yoshino T, Kimura T, Nagumo Y, Ishituka R, Mitsuzuka K, Narita S, Kobayashi T, Matsui Y, Ogawa O, Sugimoto M, Miyazaki J, Nishiyama H.
PLoS One. 2019 Aug 1;14(8):e0220173. doi: 10.1371/journal.pone.0220173. eCollection 2019.

Efficacy of Immediate Postoperative Instillation of Chemotherapy for Primary Non-Muscle-Invasive Bladder Cancer in Real-World Clinical Practice.

Murakami K, Hamada A, Teramoto Y, Matsumoto K, Kita Y, Saito R, Yamasaki T, Matsui Y, Inoue T, Ogawa O, Kobayashi T.
Clin Genitourin Cancer. 2019 Oct;17(5):e1003-e1010. doi: 10.1016/j.clgc.2019.05.028. Epub 2019 May 30.

Sleep Disturbance Worsens Lower Urinary Tract Symptoms: The Nagahama Study.

Fukunaga A, Kawaguchi T, Funada S, Yoshino T, Tabara Y, Matsuda F, Yoshimura K, Ogawa O, Negoro H; Nagahama Study Group.
J Urol. 2019 Aug;202(2):354. doi: 10.1097/JU.0000000000000212. Epub 2019 Jul 8.

The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients.

Terada N, Kamoto T, Tsukino H, Mukai S, Akamatsu S, Inoue T, Ogawa O, Narita S, Habuchi T, Yamashita S, Mitsuzuka K, Arai Y, Kandori S, Kojima T, Nishiyama H, Kawamura Y, Shimizu Y, Terachi T, Sugi M, Kinoshita H, Matsuda T, Yamada Y, Yamamoto S, Hirama H, Sugimoto M, Kakehi Y, Sakurai T, Tsuchiya N.
BMC Cancer. 2019 Feb 15;19(1):156. doi: 10.1186/s12885-019-5342-9.

Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer.

Sumiyoshi T, Mizuno K, Yamasaki T, Miyazaki Y, Makino Y, Okasho K, Li X, Utsunomiya N, Goto T, Kobayashi T, Terada N, Inoue T, Kamba T, Fujimoto A, Ogawa O, Akamatsu S.
Sci Rep. 2019 Mar 11;9(1):4030. doi: 10.1038/s41598-019-40719-y.

Downregulation of RalGTPase-activating protein promotes invasion of prostatic epithelial cells and progression from intraepithelial neoplasia to cancer during prostate carcinogenesis.

Uegaki M, Kita Y, Shirakawa R, Teramoto Y, Kamiyama Y, Saito R, Yoshikawa T, Sakamoto H, Goto T, Akamatsu S, Yamasaki T, Inoue T, Suzuki A, Horiuchi H, Ogawa O, Kobayashi T.
Carcinogenesis. 2019 Dec 31;40(12):1535-1544. doi: 10.1093/carcin/bgz082.

Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies.

Kita Y, Hamada A, Saito R, Teramoto Y, Tanaka R, Takano K, Nakayama K, Murakami K, Matsumoto K, Akamatsu S, Yamasaki T, Inoue T, Tabata Y, Okuno Y, Ogawa O, Kobayashi T.
Br J Cancer. 2019 Dec;121(12):1027-1038. doi: 10.1038/s41416-019-0609-0. Epub 2019 Nov 1.

Comparative evaluation of the extraction and analysis of urinary phospholipids and lysophospholipids using MALDI-TOF/MS.

Li X, Nakayama K, Goto T, Akamatsu S, Shimizu K, Ogawa O, Inoue T.
Chem Phys Lipids. 2019 Sep;223:104787. doi: 10.1016/j.chemphyslip.2019.104787. Epub 2019 Jun 27.

Docetaxel-based chemotherapy combined with dexamethasone 1 mg daily oral administration for castration-resistant prostate cancer: Long-term outcomes.

Tanaka N, Nishimura K, Okajima E, Ina K, Ogawa O, Nagata H, Akakura K, Fujimoto K, Gotoh M, Teramukai S, Hirao Y.
Int J Urol. 2019 Aug;26(8):797-803. doi: 10.1111/iju.14009. Epub 2019 May 5.

A comparison of laparoendoscopic single-site surgery versus conventional procedures for laparoscopic donor nephrectomy: a Japanese multi-institutional retrospective study.

Inoue T, Miura M, Yanishi M, Furukawa J, Sato F, Nitta M, Yoshimura K, Hagiuda J, Shinoda K, Kobayashi T, Miyajima A, Nakagawa K, Oya M, Ogawa O, Mimata H, Kanayama HO, Fujisawa M, Terachi T, Matsuda T, Habuchi T; LESS and RPS Research Group in Japanese Society of Endourology.
Surg Endosc. 2019 Sep 23. doi: 10.1007/s00464-019-07119-9. Online ahead of print.

Low bladder capacity is an important predictor for comorbidity of interstitial cystitis with Hunner's lesion in patients with refractory chronic prostatitis/chronic pelvic pain syndrome.

Ueda M, Sengiku A, Kono J, Negoro H, Saito R, Yoshimura N, Ogawa O, Ueda T.
Int J Urol. 2019 Jun;26 Suppl 1:53-56. doi: 10.1111/iju.13975.

Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation.

Aizawa R, Takayama K, Nakamura K, Inoue T, Yamasaki T, Kobayashi T, Akamatsu S, Ogawa O, Mizowaki T.
Int J Clin Oncol. 2019 Oct;24(10):1247-1255. doi: 10.1007/s10147-019-01478-y. Epub 2019 May 31.

Consecutive Prostate Cancer Specimens Revealed Increased Aldo-Keto Reductase Family 1 Member C3 Expression with Progression to Castration-Resistant Prostate Cancer.

Miyazaki Y, Teramoto Y, Shibuya S, Goto T, Okasho K, Mizuno K, Uegaki M, Yoshikawa T, Akamatsu S, Kobayashi T, Ogawa O, Inoue T.
J Clin Med. 2019 May 1;8(5):601. doi: 10.3390/jcm8050601.

Association of Missense Polymorphism in HSD3B1 With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or Abiraterone.

Shiota M, Narita S, Akamatsu S, Fujimoto N, Sumiyoshi T, Fujiwara M, Uchiumi T, Habuchi T, Ogawa O, Eto M.
JAMA Netw Open. 2019 Feb 1;2(2):e190115. doi: 10.1001/jamanetworkopen.2019.0115.

Laparoscopic radical cystectomy in octogenarians: analysis of a Japanese multicenter cohort.

Ito K, Kanno T, Sawada A, Saito R, Kobayashi T, Yamada H, Inoue T, Ogawa O.
Int J Clin Oncol. 2019 Sep;24(9):1081-1088. doi: 10.1007/s10147-019-01446-6. Epub 2019 Apr 10.

Complications and reoperations after laparoscopic radical cystectomy in a Japanese multicenter cohort.

Kanno T, Ito K, Sawada A, Saito R, Kobayashi T, Yamada H, Inoue T, Ogawa O.　
Int J Urol. 2019 Apr;26(4):493-498. doi: 10.1111/iju.13917. Epub 2019 Feb 1.

Data processing on a comparative evaluation of the extraction and analysis procedures for urinary phospholipid and lysophospholipid using MALDI-TOF/MS.

Li X, Nakayama K, Goto T, Akamatsu S, Shimizu K, Ogawa O, Inoue T.
Data Brief. 2019 Jul 15;25:104275. doi: 10.1016/j.dib.2019.104275. eCollection 2019 Aug.

'Trifecta' outcomes of robot-assisted partial nephrectomy: a large Japanese multicenter study.

Furukawa J, Kanayama H, Azuma H, Inoue K, Kobayashi Y, Kashiwagi A, Segawa T, Takahashi Y, Horie S, Ogawa O, Takenaka A, Shiroki R, Tanabe K, Fujisawa M.
Int J Clin Oncol. 2020 Feb;25(2):347-353. doi: 10.1007/s10147-019-01565-0. Epub 2019 Nov 1.

Impact of tumor size on patient survival after radical nephrectomy for pathological T3a renal cell carcinoma.

Sugiyama Y, Yatsuda J, Murakami Y, Ito N, Yamasaki T, Mikami Y, Ogawa O, Kamba T.
Jpn J Clin Oncol. 2019 May 1;49(5):465-472. doi: 10.1093/jjco/hyy200.

Initial evaluation of PET/CT with 18 F-FSU-880 targeting prostate-specific membrane antigen in prostate cancer patients.

Saga T, Nakamoto Y, Ishimori T, Inoue T, Shimizu Y, Kimura H, Akamatsu S, Goto T, Watanabe H, Kitaguchi K, Watanabe M, Ono M, Saji H, Ogawa O, Togashi K.
Cancer Sci. 2019 Feb;110(2):742-750. doi: 10.1111/cas.13911. Epub 2019 Jan 4.

Laparoscopic excision of an acquired ureteral diverticulum: A case report.

Negoro H, Inoue T, Imai K, Goto T, Sawada A, Akamatsu S, Saito R, Kobayashi T, Yamasaki T, Ogawa O.
Asian J Endosc Surg. 2019 Oct;12(4):478-481. doi: 10.1111/ases.12663. Epub 2018 Oct 24.

[Clinical Effect of Nivolumab on Advanced Renal Cell Carcinoma with Peritoneal Metastasis].

Hida T, Yamasaki T, Banno H, Fuchigami Y, Hattahara K, Fujiwara M, Suzuki R, Kita Y, Yoshino T, Goto T, Sawada A, Akamatsu S, Saito R, Kobayashi T, Inoue T, Ogawa O.
Hinyokika Kiyo. 2019 Oct;65(10):413-419. doi: 10.14989/ActaUrolJap_65_10_413.　 Japanese.

[Post-Operative Urethral Stricture after Holmium Laser Enucleation of the Prostate].

Imai K, Negoro H, Takashima Y, Goto T, Sawada A, Akamatsu S, Saito R, Kobayashi T, Yamasaki T, Inoue T, Ogawa O.
Hinyokika Kiyo. 2019 Nov;65(11):445-449. doi: 10.14989/ActaUrolJap_65_11_445.　 Japanese.

[The Safety of Laparoscopic Radical Cystectomy during Initial Phases in a Japanese Multicenter Cohort].

Kanno T, Inoue T, Ito K, Kono Y, Kawanishi H, Okumura K, Yamada H, Kubota M, Kawakita M, Fujii M, Terada N, Kamoto T, Shimizu Y, Ito N, Tanoue K, Kamba T, Kobori G, Moroi S, Hamada A, Masui K, Shichiri Y, Shibasaki N, Akao T, Sawada A, Saito R, Kobayashi T, Ogawa O.
Hinyokika Kiyo. 2019 Nov;65(11):439-444. doi: 10.14989/ActaUrolJap_65_11_439.　 Japanese.

[A Case of Advanced Right Renal Pelvic Cancer with Left Supraclavicular Lymph Node Metastasis that Attained Long-Term Survival by Multidisciplinary Treatments].

Imai K, Inoue T, Saito R, Goto T, Sawada A, Akamatsu S, Negoro H, Kobayashi T, Terada N, Yamasaki T, Okubo K, Yoshimura K, Kanematsu A, Ogawa O.
Hinyokika Kiyo. 2019 Jan;65(1):13-17. doi: 10.14989/ActaUrolJap_65_1_13.　 Japanese.

[Kidney Auto-Transplantation for Intraoperative Right Renal Artery Injury in a Single Kidney Patient : A Case Report].

Magaribuchi T, Kobayashi T, Kamo N, Kaido T, Sakai K, Teramoto Y, Ito K, Kubota M, Takada H, Sawada A, Akamatsu S, Yamasaki T, Inoue T, Yanagita M, Uemoto S, Ogawa O.
Hinyokika Kiyo. 2019 Nov;65(11):455-458. doi: 10.14989/ActaUrolJap_65_11_455.　 Japanese.

Salvage Radiotherapy Versus Hormone Therapy for Prostate-specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open-label, Phase 3 Trial (JCOG0401)†.

Yokomizo A, Wakabayashi M, Satoh T, Hashine K, Inoue T, Fujimoto K, Egawa S, Habuchi T, Kawashima K, Ishizuka O, Shinohara N, Sugimoto M, Yoshino Y, Nihei K, Fukuda H, Tobisu KI, Kakehi Y, Naito S; JCOG0401 Investigators.
Eur Urol. 2019 Dec 19. pii: S0302-2838(19)30896-6. doi: 10.1016/j.eururo.2019.11.023. [Epub ahead of print].

LacdiNAc-glycosylated Prostate-Specific Antigen density is a potential biomarker of prostate.

Inoue T, Kaneko T, Muramatsu S, Kimura H, Yoshino T, Goto T, Sawada A, Akamatsu S, Kobayashi T, Yamasaki T, Kaya T, Ogawa O.
cancer 2019 Clin Genitourin Cancer. S1558-7673(19)30315-5.

Editorial Comment to Prognostic Significance of Risk Stratification in CHAARTED and LATITUDE Studies Among Japanese Men With De Novo Metastatic Prostate Cancer.

Inoue T.
2019 Mar;26(3):428. doi: 10.1111/iju.13887. Epub 2018 Dec 21.

Comparison of Commercial ELISA Kits, a Prototype Multiplex Electrochemoluminescent Assay, and a Multiplex Bead-Based Immunoassay for Detecting a Urine-Based Bladder-Cancer-Associated Diagnostic Signature.

Furuya H, Pagano I, Chee K, Kobayashi T, Wong RS, Lee R, Rosser CJ.
Int J Urol 2019 Mar;26(3):428. doi: 10.1111/iju.13887. Epub 2018 Dec 21.

Combined laparoscopic and cystoscopic surgery for colovesical fistula due to colonic diverticulitis.

Kawada K, Kobayashi T, Watanabe T, Inamoto S, Goto T, Mizuno R, Sakai Y.
Tech Coloproctol. 2019 May;23(5):503-504. doi: 10.1007/s10151-019-01981-4. Epub 2019 Apr 16.

The cortical rim sign in graft renal infarction.

Muro K, Kobayashi T, Yanagita M.
Clin Exp Nephrol. 23(9):1169-1170, 2019.

PEG10 is associated with treatment-induced neuroendocrine prostate cancer.

Kim S, Thaper D, Bidnur S, Toren P, Akamatsu S, Bishop JL, Colins C, Vahid S, Zoubeidi A.
J Mol Endocrinol. 2019 Jul 1;63(1):39-49. doi: 10.1530/JME-18-0226.

Arteriovenous fistula after robot‐assisted laparoscopic prostatectomy: A rare case report.

Suzuki R, Goto T, Kohno S, Kita Y, Shimizu H, Kobayashi T, Yamasaki T, Ogawa O, and Inoue T.(2019)
IJU Case Rep. 2019 2: 184-186. doi:10.1002/iju5.12072.

2018

論文・依頼原稿

Clinical and Molecular Features of Treatment-Related Neuroendocrine Prostate Cancer.

Akamatsu S, Inoue T, Ogawa O, Gleave ME.
Int J Urol. 2018 Apr;25(4):345-351. doi: 10.1111/iju.13526. Epub 2018 Feb 3.

Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan.

Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Itoh H, Umakoshi H, Tsuiki M, Ichijo T, Katabami T, Tanaka Y, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Yoneda T, Hashimoto S, Yanase T, Suzuki T, Kawamura T, Tabara Y, Matsuda F, Naruse M; Nagahama Study; JPAS Study Group.
Hypertension. 2018 Mar;71(3):530-537. doi: 10.1161/HYPERTENSIONAHA.117.10263. Epub 2018 Jan 22.

Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism.

Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Umakoshi H, Ichijo T, Katabami T, Wada N, Ogawa Y, Yoshimoto T, Kawashima J, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Miyauchi S, Kamemura K, Fukuoka T, Yamamoto K, Otsuki M, Suzuki T, Naruse M; JPAS Study Group.
J Clin Endocrinol Metab. 2018 Dec 1;103(12):4456-4464. doi: 10.1210/jc.2018-00866.

Bladder urothelial carcinoma producing insulin‐like growth factor II: A case report.

Funada S, Kita Y, Yoshiyuki Okada, Takashi Kobayashi, Yuki Teramoto, Shinsuke Shibuya, Ryoichi Saito, Kaoru Murakami, Keiyu Matsumoto, Yang Feng, Dimiter S. Dimitrov, Takahiro Inoue, Osamu Ogawa.
IJU Case reports 2018 Sep; 1(1): 9-12 doi: 10.1002/iju5.12018.

Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community-based multi-institutional database across Japan using propensity score matching.

Onozawa M, Akaza H, Hinotsu S, Oya M, Ogawa O, Kitamura T, Suzuki K, Naito S, Namiki M, Nishimura K, Hirao Y, Tsukamoto T.
Cancer Med. 2018 Oct;7(10):4893-4902. doi: 10.1002/cam4.1735. Epub 2018 Aug 27.

Efficacy and Safety of Carboplatin Plus Paclitaxel as the First-, Second-, and Third-line Chemotherapy in Men With Castration-resistant Prostate Cancer.

Fujiwara M, Akamatsu S, Sumiyoshi T, Segawa T, Mizuno K, Yoshino T, Goto T, Sawada A, Saito R, Kobayashi T, Yamasaki T, Inoue T, Ogawa O.
Clin Genitourin Cancer. 2019 Oct;17(5):e923-e929. doi: 10.1016/j.clgc.2019.04.017. Epub 2019 Jun 12.

Circadian rhythms of micturition during jet lag.

Ito K, Yasuda M, Maeda Y, Fustin JM, Yamaguchi Y, Kono Y, Negoro H, Kanematsu A, Ogawa O, Doi M, Okamura H.
Biomed Res. 2018;39(2):57-63. doi: 10.2220/biomedres.39.57.

Urinary Protein Markers for the Detection and Prognostication of Urothelial Carcinoma.

Szarvas T, Nyirády P, Ogawa O, Furuya H, Rosser CJ, Kobayashi T.
Methods Mol Biol. 2018;1655:251-273. doi: 10.1007/978-1-4939-7234-0_19.

Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges.

Kita Y, Goto T, Akamatsu S, Yamasaki T, Inoue T, Ogawa O, Kobayashi T.
Cancers (Basel). 2018 Sep 21;10(10):345. doi: 10.3390/cancers10100345.

Re: Comprehensive Molecular Characterization of Muscle-invasive Bladder Cancer.

Saito R, Kobayashi T, Ogawa O.
Eur Urol. 2018 May;73(5):808-809. doi: 10.1016/j.eururo.2017.12.010. Epub 2017 Dec 20.

Gliding Basal Cell Migration of the Urothelium during Wound Healing.

Sano T, Kobayashi T, Ogawa O, Matsuda M.
Am J Pathol. 2018 Nov;188(11):2564-2573. doi: 10.1016/j.ajpath.2018.07.010. Epub 2018 Aug 16.

[Initial Clinical Experience of Nivolumab for Metastatic Renal Cell Carcinoma].

Fukunaga A, Yamasaki T, Okuno T, Imai K, Ikeuchi R, Hishiki K, Goto T, Sawada A, Negoro H, Akamatsu S, Saito R, Kobayashi T, Inoue T, Ogawa O.
Hinyokika Kiyo. 2018 Oct;64(10):383-389. doi: 10.14989/ActaUrolJap_64_10_383.　 Japanese.

Glucocorticoid receptor expression in resident and hematopoietic cells in IgG4-related disease.

Iguchi T, Takaori K, Mii A, Sato Y, Suzuki Y, Yoshifuji H, Seno H, Ogawa O, Omori K, Bessho K, Kondo S, Yoshizaki T, Nakashima H, Saito T, Mimori T, Haga H, Kawano M, Yanagita M.
Mod Pathol. 2018 Jun;31(6):890-899. doi: 10.1038/s41379-018-0036-4. Epub 2018 Feb 12.

[Clinical Utility of Upper Urinary Tract Reconstruction by Ileal-Ureter Substitution].

Okumura Y, Akamatsu S, Okada Y, Negoro H, Kobayashi T, Terada N, Yamasaki T, Matsui Y, Inoue T, Kamba T, Ogawa O.
Hinyokika Kiyo. 2018 Mar;64(3):87-94. doi: 10.14989/ActaUrolJap_64_3_87.　 Japanese.

Evaluation of quantitative parameters for distinguishing pheochromocytoma from other adrenal tumors.

Ohno Y, Sone M, Taura D, Yamasaki T, Kojima K, Honda-Kohmo K, Fukuda Y, Matsuo K, Fujii T, Yasoda A, Ogawa O, Inagaki N.
Hypertens Res. 2018 Mar;41(3):165-175. doi: 10.1038/s41440-017-0002-4. Epub 2018 Jan 18.

Long-term outcomes of definitive external-beam radiotherapy for non-metastatic castration-resistant prostate cancer.

Aizawa R, Takayama K, Nakamura K, Inoue T, Kobayashi T, Akamatsu S, Yamasaki T, Ogawa O, Mizowaki T.
Int J Clin Oncol. 2018 Aug;23(4):749-756. doi: 10.1007/s10147-018-1265-8. Epub 2018 Mar 19.

Circadian coordination of ATP release in the urothelium via connexin43 hemichannels.

Sengiku A, Ueda M, Kono J, Sano T, Nishikawa N, Kunisue S, Tsujihana K, Liou LS, Kanematsu A, Shimba S, Doi M, Okamura H, Ogawa O, Negoro H.
Sci Rep. 2018 Jan 31;8(1):1996. doi: 10.1038/s41598-018-20379-0.

Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer.

Masuda N, Ogawa O, Park M, Liu AY, Goodison S, Dai Y, Kozai L, Furuya H, Lotan Y, Rosser CJ, Kobayashi T.
Oncotarget. 2018 Jan 3;9(6):7101-7111. doi: 10.18632/oncotarget.23872. eCollection 2018 Jan 23.

Intravesical prostatic protrusion is not always the same shape: Evaluation by preoperative cystoscopy and outcome in HoLEP.

Ito K, Takashima Y, Akamatsu S, Terada N, Kobayashi T, Yamasaki T, Inoue T, Kamba T, Ogawa O, Negoro H.
Neurourol Urodyn. 2018 Sep;37(7):2160-2166. doi: 10.1002/nau.23428. Epub 2018 Aug 10.

[Two Cases of Metastatic and Recurrent Non-Clear Cell Renal Cell Carcinoma Re-Diagnosed as Renal Mucinous Tubular and Spindle Cell Carcinoma during Long-Term Follow-Up].

Kubota M, Yamasaki T, Teramoto Y, Ito K, Takada H, Magaribuchi T, Sawada A, Akamatsu S, Negoro H, Saito R, Kobayashi T, Terada N, Inoue T, Kamba T, Ogawa O.
Hinyokika Kiyo. 2018 Mar;64(3):111-115. doi: 10.14989/ActaUrolJap_64_3_111.　 Japanese.

Impact of a robotic surgical system on treatment choice for men with clinically organ-confined prostate cancer.

Kobayashi T, Kanao K, Araki M, Terada N, Kobayashi Y, Sawada A, Inoue T, Ebara S, Watanabe T, Kamba T, Sumitomo M, Nasu Y, Ogawa O.
Int J Clin Oncol. 2018 Apr;23(2):347-352. doi: 10.1007/s10147-017-1203-1. Epub 2017 Nov 11.

Cross-Sectional Epidemiological Analysis of the Nagahama Study for Correlates of Overactive Bladder: Genetic and Environmental Considerations.

Funada S, Kawaguchi T, Terada N, Negoro H, Tabara Y, Kosugi S, Yamada R, Nakayama T, Akamatsu S, Yoshimura K, Matsuda F, Ogawa O; Nagahama Study Group.
J Urol. 2018 Mar;199(3):774-778. doi: 10.1016/j.juro.2017.09.146. Epub 2017 Oct 21.

Spinal Epidural Abscess Following Prostate Biopsy.

Fukunaga A, Negoro H, Takada H, Terada N, Okuno T, Imai K, Ikeuchi R, Hishiki K, GotoT, Sawada A, Akamatsu S, Saito R, Kobayashi T1, Yamasaki T, Inoue T, Ogawa O.
J Clin Case Rep. 1(1):1002 2018.

Sperm cryopreservation: Clinical and fertility outcomes in male oncological patients with germ cell tumors or hematological disorders.

Negoro H, Matsui Y, Nakayama T, Hatayama H, Ogawa O, Ichioka K.
Reprod Med Biol. 2018 Sep 30;17(4):500-503. doi: 10.1002/rmb2.12246. eCollection 2018 Oct.

High incidence of BK virus-associated hemorrhagic cystitis in children after second or third allogeneic hematopoietic stem cell transplantation.

Umeda K, Kato I, Kawaguchi K, Tasaka K, Kamitori T, Ogata H, Mikami T, Hiramatsu H, Saito R, Ogawa O, Takahashi T, Adachi S.
Pediatr Transplant. 2018 Jun;22(4):e13183. doi: 10.1111/petr.13183. Epub 2018 Apr 14.

A pilot study of highly hypofractionated intensity-modulated radiation therapy over 3 weeks for localized prostate cancer.

Nakamura K, Ikeda I, Inokuchi H, Takayama K, Inoue T, Kamba T, Ogawa O, Hiraoka M, Mizowaki T.
J Radiat Res. 2018 Sep 1;59(5):656-663. doi: 10.1093/jrr/rry060.

Decreased acute toxicities of intensity-modulated radiation therapy for localized prostate cancer with prostate-based versus bone-based image guidance.

Nakamura K, Mizowaki T, Inokuchi H, Ikeda I, Inoue T, Kamba T, Ogawa O, Hiraoka M.
Int J Clin Oncol. 2018 Feb;23(1):158-164. doi: 10.1007/s10147-017-1174-2. Epub 2017 Jul 29.

A family case with germline TSC1 and mtDNA mutations developing bilateral eosinophilic chromophobe renal cell carcinomas without other typical phenotype of tuberous sclerosis.

Sakamoto H, Yamasaki T, Sumiyoshi T, Utsunomiya N, Takeda M, Kamba T, Nakamura E, Ogawa O.
J Clin Pathol. 2018 Oct;71(10):936-943. doi: 10.1136/jclinpath-2018-205211. Epub 2018 Jun 30.

Recovery of Serum Testosterone Levels and Sexual Function in Patients Treated With Short-term Luteinizing Hormone-releasing Hormone Antagonist as a Neoadjuvant Therapy Before External Radiotherapy for Intermediate-risk Prostate Cancer: Preliminary Prospective Study.

Inoue T, Mizowaki T, Kabata D, Shintani A, Terada N, Yamasaki T, Negoro H, Kobayashi T, Nakamura K, Inokuchi H, Ogawa O.
Clin Genitourin Cancer. 2018 Apr;16(2):135-141.e1. doi: 10.1016/j.clgc.2017.09.009. Epub 2017 Sep 23.

[Kidney in a bag method: A useful procedure for managing renal vessels in laparoscopic donor nephrectomy].

Negoro H, Yamasaki T, Kobayashi T, Matsui Y, Ogawa O, Inoue T.
J. Jpn. Soc. Endosc. Surg. 23:127-130 2018.

[Biological clock and nocturia] Journal of Clinical and Experimental Medicine.

Negoro H, Sengiku A.
267(6) 457-461 2018.

[Epidemiology, pathophysiology and diagnosis of nocturia] Japanese Journal of Clinical Urology.

Negoro H.
72:104-110 2018.

The impact of time to metastasis on overall survival in patients with prostate cancer.

Frees S, Akamatsu S, Bidnur S, Khalaf D, Chavez-Munoz C, Struss W, Eigl BJ, Gleave M, Chi KN, So A.
World J Urol. 2018 Jul;36(7):1039-1046. doi: 10.1007/s00345-018-2236-4. Epub 2018 Feb 27.

The usefulness of testosterone administration in identifying false-positive elevation of serum human chorionic gonadotropin in patients with germ cell tumor.

Takizawa A, Kawai K, Kawahara T, Kojima T, Maruyama S, Shinohara N, Akamatsu S, Kamba T, Nakamura T, Ukimura O, Jikuya R, Kishida T, Kakimoto K, Nishimura K, Harabayashi T, Nagamori S, Yamashita S, Arai Y, Sawada Y, Sekido N, Kinoshita H, Matsuda T, Nakagawa T, Homma Y, Nishiyama H.
J Cancer Res Clin Oncol. 2018 Jan;144(1):109-115. doi: 10.1007/s00432-017-2520-5. Epub 2017 Sep 13.

Peritoneal Tuberculosis After Robot-Assisted Laparoscopic Prostatectomy with Extended Lymph Node Dissection.

Saito S, Ito K, Matsumoto K, Tajima M, Goto T, Ito H, Manabe Y, Mishina M, Okuno H.
J Endourol Case Rep. 2018 Apr 1;4(1):48-50. doi: 10.1089/cren.2018.0018. eCollection 2018.

2017

論文・依頼原稿

Impact of a robotic surgical system on treatment choice for men with clinically organ-confined prostate cancer.

Kobayashi T, Kanao K, Araki M, Terada N, Kobayashi Y, Sawada A, Inoue T, Ebara S, Watanabe T, Kamba T, Sumitomo M, Nasu Y, Ogawa O.
Int J Clin Oncol. 2017 Nov 11. doi: 10.1007/s10147-017-1203-1. [Epub ahead of print]

Cross-Sectional Epidemiological Analysis of the Nagahama Study for Correlates of Overactive Bladder: Genetic and Environmental Considerations.

Funada S, Kawaguchi T, Terada N, Negoro H, Tabara Y, Kosugi S, Yamada R, Nakayama T, Akamatsu S, Yoshimura K, Matsuda F, Ogawa O; Nagahama Study Group.
J Urol. 2017 Oct 21. pii: S0022-5347(17)77774-9. doi: 10.1016/j.juro.2017.09.146. [Epub ahead of print]

Recovery of Serum Testosterone Levels and Sexual Function in Patients Treated With Short-term Luteinizing Hormone-releasing Hormone Antagonist as a Neoadjuvant Therapy Before External Radiotherapy for Intermediate-risk Prostate Cancer: Preliminary Prospective Study.

Inoue T, Mizowaki T, Kabata D, Shintani A, Terada N, Yamasaki T, Negoro H, Kobayashi T, Nakamura K, Inokuchi H, Ogawa O.
Clin Genitourin Cancer. 2017 Sep 23. pii: S1558-7673(17)30284-7. doi: 10.1016/j.clgc.2017.09.009. [Epub ahead of print]

Bowel perforation by a peritoneal dialysis catheter: report of two cases.

Fujiwara M, Soda T, Okada T, Kanamaru H, Inoue T, Ogawa O.
BMC Nephrol. 2017 Oct 16;18(1):312. doi: 10.1186/s12882-017-0737-9. BMC Nephrol. 2017 Oct 16;18(1):312. doi: 10.1186/s12882-017-0737-9.

[Simultaneous Hepatorenal Transplantation from a Brain-Dead Donor for Graft Dysfunction and Renal Insufficiency in a Liver Transplant Recipient : A Case Report].

Takada H, Kobayashi T, Ogawa K, Miyata H, Sawada A, Akamatsu S, Negoro H, Saito R, Terada N, Yamasaki T, Inoue T, Teramoto Y, Shibuya S, Haga H, Kaido T, Uemoto S, Ogawa O.
Hinyokika Kiyo. 2017 Aug;63(8):313-318. doi: 10.14989/ActaUrolJap_63_8_313. Japanese.

Urinary Protein Markers for the Detection and Prognostication of Urothelial Carcinoma.

Szarvas T, Nyirady P, Kobayashi T, Ogawa O, Rosser CJ, Furuya H.
Methods Mol Biol. 2018;1655:251-273. doi: 10.1007/978-1-4939-7234-0_19.

Safe and effective administration of BCG for bladder carcinoma in situ after umbilical cord blood stem cell transplantation.

Magaribuchi T, Akamatsu S, Kobayashi T, Kawabata H, Yamasaki T, Inoue T, Ogawa O.
Transpl Infect Dis. 2017 Aug 10. doi: 10.1111/tid.12758. [Epub ahead of print]

Prognostic and predictive biomarkers in prostate cancer: latest evidence and clinical implications.

Terada N, Akamatsu S, Kobayashi T, Inoue T, Ogawa O, Antonarakis ES.
Ther Adv Med Oncol. 2017 Aug;9(8):565-573. doi: 10.1177/1758834017719215. Epub 2017 Jul 5. Review.

Decreased acute toxicities of intensity-modulated radiation therapy for localized prostate cancer with prostate-based versus bone-based image guidance.

Nakamura K, Mizowaki T, Inokuchi H, Ikeda I, Inoue T, Kamba T, Ogawa O, Hiraoka M.
Int J Clin Oncol. 2017 Jul 29. doi: 10.1007/s10147-017-1174-2. [Epub ahead of print]

Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.

Inokuchi J, Kuroiwa K, Kakehi Y, Sugimoto M, Tanigawa T, Fujimoto H, Gotoh M, Masumori N, Ogawa O, Eto M, Ohyama C, Yamaguchi A, Matsuyama H, Ichikawa T, Asano T, Mizusawa J, Eba J, Naito S.
World J Urol. 2017 Nov;35(11):1737-1744. doi: 10.1007/s00345-017-2049-x. Epub 2017 May 15.

[A Case of Thyroid-Like Follicular Carcinoma of the Kidney].

Ito K, Negoro H, Kubota M, Takada H, Magaribuchi T, Sawada A, Akamatsu S, Kobayashi T, Terada N, Yamasaki T, Inoue T, Kamba T, Teramoto Y, Ogawa O.
Hinyokika Kiyo. 2017 Apr;63(4):145-149. doi: 10.14989/ActaUrolJap_63_4_145. Review. Japanese.

A 45,X/46,XY Male with Orchidopexy Diagnosed with Mixed Germ Cell Tumor After 21-year Follow-up.

Kubota M, Terada N, Ito K, Takada H, Magaribuchi T, Sawada A, Akamatsu S, Negoro H, Saito R, Kobayashi T, Yamasaki T, Inoue T, Ogawa O.
Urol Case Rep. 2017 May 5;13:120-122. doi: 10.1016/j.eucr.2017.04.001. eCollection 2017 Jul.

Dietary Sodium Restriction Reduces Nocturnal Urine Volume and Nocturnal Polyuria Index in Renal Allograft Recipients With Nocturnal Polyuria.

Okumura Y, Asai K, Kobayashi T, Miyata H, Tanaka Y, Okada Y, Sakai K, Kamba T, Tsuji H, Shide K, Nagashima K, Yanagita M, Inagaki N, Ogawa O, Negoro H.
Urology. 2017 Aug;106:60-64. doi: 10.1016/j.urology.2017.04.025. Epub 2017 Apr 26.

Exploring the optimal sequence of abiraterone and enzalutamide in patients with chemotherapy-naïve castration-resistant prostate cancer: The Kyoto-Baltimore collaboration.

Terada N, Maughan BL, Akamatsu S, Kobayashi T, Yamasaki T, Inoue T, Kamba T, Ogawa O, Antonarakis ES.
Int J Urol. 2017 Jun;24(6):441-448. doi: 10.1111/iju.13346. Epub 2017 Apr 28.

Patient-derived xenografts as in vivo models for research in urological malignancies.

Inoue T, Terada N, Kobayashi T, Ogawa O.
Nat Rev Urol. 2017 May;14(5):267-283. doi: 10.1038/nrurol.2017.19. Epub 2017 Feb 21. Review.

Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.

Okada Y, Sonoshita M, Kakizaki F, Aoyama N, Itatani Y, Uegaki M, Sakamoto H, Kobayashi T, Inoue T, Kamba T, Suzuki A, Ogawa O, Taketo MM.
Cancer Sci. 2017 Apr;108(4):744-752. doi: 10.1111/cas.13187. Epub 2017 Apr 12.

Nocturia increases the incidence of depressive symptoms: a longitudinal study of the HEIJO-KYO cohort.

Obayashi K, Saeki K, Negoro H, Kurumatani N.
BJU Int. 2017 Aug;120(2):280-285. doi: 10.1111/bju.13791. Epub 2017 Feb 17.

2016

論文・依頼原稿

Development of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE Samples.

Kurobe M, Kojima T, Nishimura K, Kandori S, Kawahara T, Yoshino T, Ueno S, Iizumi Y, Mitsuzuka K, Arai Y, Tsuruta H, Habuchi T, Kobayashi T, Matsui Y, Ogawa O, Sugimoto M, Kakehi Y, Nagumo Y, Tsutsumi M, Oikawa T, Kikuchi K, Nishiyama H.
PLoS One. 2016 Dec 8;11(12):e0165109. doi: 10.1371/journal.pone.0165109. eCollection 2016 Dec 8.

[Deceased Donor Kidney Transplantation from a Liver Transplantation Recipient].

Koike S, Kobayashi T, Okada Y, Shibuya S, Sakai K, Tanaka Y, Akamatsu S, Negoro H, Terada N, Yamasaki T, Matsui Y, Inoue T, Kamba T, Umeya Y, Kaido T, Ogawa O.
Hinyokika Kiyo. 2016 Oct;62(10):529-534. doi: 10.14989/ActaUrolJap_62_10_529. Japanese.

Intravital imaging of mouse urothelium reveals activation of extracellular signal-regulated kinase by stretch-induced intravesical release of ATP.

Sano T, Kobayashi T, Negoro H, Sengiku A, Hiratsuka T, Kamioka Y, Liou LS, Ogawa O, Matsuda M.
Physiol Rep. 2016 Nov;4(21). pii: e13033. Epub 2016 Nov 15.

CCL2 as a potential therapeutic target for clear cell renal cell carcinoma.

Arakaki R, Yamasaki T, Kanno T, Shibasaki N, Sakamoto H, Utsunomiya N, Sumiyoshi T, Shibuya S, Tsuruyama T, Nakamura E, Ogawa O, Kamba T.
Cancer Med. 2016 Oct;5(10):2920-2933. doi: 10.1002/cam4.886. Epub 2016 Sep 26.

Evaluation of predictors of unfavorable pathological features in men eligible for active surveillance using radical prostatectomy specimens: a multi-institutional study.

Mizuno K, Inoue T, Kinoshita H, Yano T, Kawanishi H, Kanda H, Terada N, Kobayashi T, Kamba T, Mikami Y, Shiraishi T, Uemura Y, Imai Y, Honjo G, Shirase T, Okumura K, Kawakita M, Ogura K, Sugimura Y, Matsuda T, Ogawa O.
Jpn J Clin Oncol. 2016 Dec;46(12):1156-1161. Epub 2016 Oct 15.

A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort.

Goodison S, Ogawa O, Matsui Y, Kobayashi T, Miyake M, Ohnishi S, Fujimoto K, Dai Y, Shimizu Y, Tsukikawa K, Furuya H, Rosser CJ.
J Transl Med. 2016 Oct 7;14(1):287.

Heterogeneous fibroblasts underlie age-dependent tertiary lymphoid tissues in the kidney.

Sato Y, Mii A, Hamazaki Y, Fujita H, Nakata H, Masuda K, Nishiyama S, Shibuya S, Haga H, Ogawa O, Shimizu A, Narumiya S, Kaisho T, Arita M, Yanagisawa M, Miyasaka M, Sharma K, Minato N, Kawamoto H, Yanagita M.
JCI Insight. 2016 Jul 21;1(11):e87680.

Asia prostate cancer study (A-CaP Study) launch symposium.

Akaza H, Hirao Y, Kim CS, Oya M, Ozono S, Ye D, Cooperberg M, Hinotsu S, Lee JY, Zhu G, Namiki M, Horie S, Chung BH, Chen CH, Fai NC, Hakim L, Chiong E, Letran J, Umbas R, Suzuki K, Nishimura K, Ong TA, Lojanapiwat B, Wu TL, Kim WJ, Murphy D, Ogawa O, Carroll P, Naito S, Tsukamoto T.
Prostate Int. 2016 Sep;4(3):88-96. doi: 10.1016/j.prnil.2016.03.001. Epub 2016 Mar 10.

Population Pharmacokinetics of Everolimus in Relation to Clinical Outcomes in Patients With Advanced Renal Cell Carcinoma.

Tanaka A, Yano I, Shinsako K, Sato E, Fukudo M, Masuda S, Yamasaki T, Kamba T, Ogawa O, Matsubara K.
Ther Drug Monit. 2016 Dec;38(6):663-669.

A phase III multicenter, randomized, controlled study of combined androgen blockade with versus without zoledronic acid in prostate cancer patients with metastatic bone disease: results of the ZAPCA trial.

Kamba T, Kamoto T, Maruo S, Kikuchi T, Shimizu Y, Namiki S, Fujimoto K, Kawanishi H, Sato F, Narita S, Satoh T, Saito H, Sugimoto M, Teishima J, Masumori N, Egawa S, Sakai H, Okada Y, Terachi T, Ogawa O; ZAPCA Study Group..
Int J Clin Oncol. 2017 Feb;22(1):166-173. doi: 10.1007/s10147-016-1037-2. Epub 2016 Sep 10.

The Short-Term Impact of Dietary Counseling on Sodium Intake and Blood Pressure in Renal Allograft Recipients.

Asai K, Kobayashi T, Miyata H, Tanaka Y, Okada Y, Sakai K, Negoro H, Kamba T, Tsuji H, Shide K, Yanagita M, Inagaki N, Ogawa O.
Prog Transplant. 2016 Aug 28. pii: 1526924816664084. [Epub ahead of print]

Factors predicting efficacy and adverse effects of enzalutamide in Japanese patients with castration-resistant prostate cancer: results of retrospective multi-institutional study.

Terada N, Akamatsu S, Okada Y, Negoro H, Kobayashi T, Yamasaki T, Matsui Y, Inoue T, Kamba T, Ogawa O.
Int J Clin Oncol. 2016 Dec;21(6):1155-1161. Epub 2016 Jun 28.

Current status of systemic chemotherapy for octogenarians with advanced urothelial cancer in Japan: a Japanese multi-institutional study (CURE study).

Matsui Y, Ogawa O, Ishitsuka R, Miyazaki J, Inoue T, Kageyama S, Sugimoto M, Mitsuzuka K, Shiraishi Y, Kinoshita H, Wakeda H, Nomoto T, Kikuchi E, Fujie K, Keino N, Nishiyama H.
Int J Clin Oncol. 2016 Dec;21(6):1142-1149. Epub 2016 Jun 27.

High incidence of urological complications in men dying from prostate cancer.

Kobayashi T, Kamba T, Terada N, Yamasaki T, Inoue T, Ogawa O.
Int J Clin Oncol. 2016 Dec;21(6):1150-1154. Epub 2016 Jun 4.

Subclassification of high-risk clinically organ-confined prostate cancer for early cancer-specific mortality after radical prostatectomy.

Kobayashi T, Kimura T, Lee C, Inoue T, Terada N, Kono Y, Kamba T, Kim CS, Egawa S, Ogawa O.
Jpn J Clin Oncol. 2016 Aug;46(8):762-7. doi: 10.1093/jjco/hyw061. Epub 2016 May 20.

An original patient-derived xenograft of prostate cancer with cyst formation.

Yoshikawa T, Kobori G, Goto T, Akamatsu S, Terada N, Kobayashi T, Tanaka Y, Jung G, Kamba T, Ogawa O, Inoue T.M
Prostate. 2016 Aug;76(11):994-1003. doi: 10.1002/pros.23188. Epub 2016 Apr 21.

Prognosis of metastatic renal cell carcinoma with first-line interferon-α therapy in the era of molecular-targeted therapy.

Kawano Y, Takahashi W, Eto M, Kamba T, Miyake H, Fujisawa M, Kamai T, Uemura H, Tsukamoto T, Azuma H, Matsubara A, Nishimura K, Nakamura T, Ogawa O, Naito S.
Cancer Sci. 2016 Jul;107(7):1013-7. doi: 10.1111/cas.12951. Epub 2016 Jun 14.

Predictive value of radiological response rate for pathological response to neoadjuvant chemotherapy and post-cystectomy survival of bladder urothelial cancer.

Fukui T, Matsui Y, Umeoka S, Inoue T, Kamba T, Togashi K, Ogawa O, Kobayashi T.
Jpn J Clin Oncol. 2016 Mar 8. pii: hyw025. [Epub ahead of print]

[Advanced Adenocarcinoma of the Bladder after Augmentation Gastrocystoplasty].

Kono Y, Terada N, Takashima Y, Hikami K, Hida T, Goto S, Sunada T, Okada Y, Shibasaki N, Negoro H, Kobayashi T, Yamasaki T, Matsui Y, Inoue T, Kamba T, Ogawa O.
Hinyokika Kiyo. 2016 Jan;62(1):33-7. Review. Japanese.

Ten-year outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for intermediate- and high-risk patients with T1c-T2N0M0 prostate cancer.

Mizowaki T, Norihisa Y, Takayama K, Ikeda I, Inokuchi H, Nakamura K, Kamba T, Inoue T, Kamoto T, Ogawa O, Hiraoka M.
Int J Clin Oncol. 2016 Aug;21(4):783-90. doi: 10.1007/s10147-016-0954-4. Epub 2016 Feb 3.

Authentic role of ATP signaling in micturition reflex.

Takezawa K, Kondo M, Kiuchi H, Ueda N, Soda T, Fukuhara S, Takao T, Miyagawa Y, Tsujimura A, Matsumoto-Miyai K, Ishida Y, Negoro H, Ogawa O, Nonomura N, Shimada S.
Sci Rep. 2016 Jan 22;6:19585. doi: 10.1038/srep19585.

A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancer.

Akaza H, Uemura H, Tsukamoto T, Ozono S, Ogawa O, Sakai H, Oya M, Namiki M, Fukasawa S, Yamaguchi A, Uemura H, Ohashi Y, Maeda H, Saito A, Takeda K, Naito S.
Int J Clin Oncol. 2016 Aug;21(4):773-82. doi: 10.1007/s10147-016-0952-6. Epub 2016 Jan 21.

[Recent advancements in prostate cancer basic research].

Inoue T, Ogawa O.
Nihon Rinsho. 2016 Jan;74(1):7-12. Japanese.

Guideline adherence of immediate post-transurethral resection intravesical chemotherapy for patients with nonmuscle invasive bladder cancer.

Matsumoto K, Matsui Y, Negoro H, Terada N, Yamasaki T, Inoue T, Kamba T, Ogawa O, Kobayashi T.
Urol Prac. 2016;3(6):456-61.

Understanding the biology of urothelial cancer metastasis.

Kobayashi T.
Asian J Urol. 2016;3(4):211-22.

[Nocturia and the Circadian Rhythm]

Negoro H, Ogawa O.
PROGRESS IN MEDICINE 36(1): 15 -19 2016.

Effective and Safe Administration of Low-Dose Estramustine Phosphate for Castration-Resistant Prostate Cancer.

Inoue T, Ogura K, Kawakita M, Tsukino H, Akamatsu S, Yamasaki T, Matsui Y, Segawa T, Sugino Y, Kamoto T, Kamba T, Tanaka S, Ogawa O.
Clin Genitourin Cancer. 2016 Feb;14(1):e9-e17. doi: 10.1016/j.clgc.2015.08.008. Epub 2015 Sep 2.

Long-term outcomes of intensity-modulated radiation therapy combined with neoadjuvant androgen deprivation therapy under an early salvage policy for patients with T3-T4N0M0 prostate cancer.

Mizowaki T, Norihisa Y, Takayama K, Ikeda I, Inokuchi H, Nakamura K, Kamba T, Inoue T, Kamoto T, Ogawa O, Hiraoka M.
Int J Clin Oncol. 2016 Feb;21(1):148-55. doi: 10.1007/s10147-015-0867-7. Epub 2015 Jul 4.

2015

論文・依頼原稿

[Clinical Characteristics of Prostate Ductal Adenocarcinoma in Kyoto University Hospital].

Nakamura K, Terada N, Kobayashi T, Sugino Y, Yamasaki T, Matsui Y, Imamura M, Okubo K, Kamba T, Yoshimura K, Ogawa O.
Hinyokika Kiyo. 2015 Dec;61(12):487-91. Japanese.

CXCL1 is elevated in the urine of bladder cancer patients.

Burnier A, Shimizu Y, Dai Y, Nakashima M, Matsui Y, Ogawa O, Rosser CJ, Furuya H.
Springerplus. 2015 Oct 15;4:610. doi: 10.1186/s40064-015-1393-9.

[A Case of Rapidly Progressive Metastatic Castration-Resistant Prostate Cancer : Durable Control by Early Induction of Carboplatin and Paclitaxel].

Sunada T, Kobayashi T, Shibasaki N, Okada Y, Negoro H, Terada N, Yamasaki T, Matsui Y, Inoue T, Kamba T, Ogawa O.
Hinyokika Kiyo. 2015 Sep;61(9):369-73. Japanese.

Underweight body mass index is a risk factor of mortality in outpatients with nocturia in Japan.

Negoro H, Sugino Y, Nishizawa K, Soda T, Shimizu Y, Yoshimura K, Ogawa O, Yoshimura K.
BMC Res Notes. 2015 Sep 29;8:490. doi: 10.1186/s13104-015-1456-6.

Urine CXCL1 as a biomarker for tumor detection and outcome prediction in bladder cancer.

Nakashima M, Matsui Y, Kobayashi T, Saito R, Hatahira S, Kawakami K, Nakamura E, Nishiyama H, Ogawa O.
Cancer Biomark. 2015;15(4):357-64. doi: 10.3233/CBM-150472.

Decreased expression of lysophosphatidylcholine (16:0/OH) in high resolution imaging mass spectrometry independently predicts biochemical recurrence after surgical treatment for prostate cancer.

Goto T, Terada N, Inoue T, Kobayashi T, Nakayama K, Okada Y, Yoshikawa T, Miyazaki Y, Uegaki M, Utsunomiya N, Makino Y, Sumiyoshi S, Yamasaki T, Kamba T, Ogawa O.
Prostate. 2015 Dec;75(16):1821-30. doi: 10.1002/pros.23088. Review.

Large Retroperitoneal Mass Diagnosed as Adrenal Chronic Expanding Hematoma.

Sunada T, Kobayashi T, Furuta A, Shibuya S, Okada Y, Negoro H, Terada N, Yamasaki T, Matsui Y, Inoue T, Kamba T, Ogawa O.
Urology. 2015 Oct;86(4):e17-9. doi: 10.1016/j.urology.2015.06.043.

Long-term outcomes of intensity-modulated radiation therapy combined with neoadjuvant androgen deprivation therapy under an early salvage policy for patients with T3-T4N0M0 prostate cancer.

Mizowaki T, Norihisa Y, Takayama K, Ikeda I, Inokuchi H, Nakamura K, Kamba T, Inoue T, Kamoto T, Ogawa O, Hiraoka M.
Int J Clin Oncol. 2016 Feb;21(1):148-55. doi: 10.1007/s10147-015-0867-7.

Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma.

Shibasaki N, Yamasaki T, Kanno T, Arakaki R, Sakamoto H, Utsunomiya N, Inoue T, Tsuruyama T, Nakamura E, Ogawa O, Kamba T.
PLoS One. 2015 Jun 26;10(6):e0130980. doi: 10.1371/journal.pone.0130980.

[A case of growing teratoma syndrome; long-term control accomplished by systemic interferon therapy with adequate local therapies].

Yoshikawa T, Uegaki M, Kobayashi T, Negoro H, Yamasaki T, Segawa T, Kamoto T, Kamba T, Ogawa O.
Hinyokika Kiyo. 2015 Apr;61(4):163-6. Japanese.

Outcomes of curative nephrectomy against renal cell carcinoma based on a central pathological review of 914 specimens from the era of cytokine treatment.

Ito N, Kojima S, Teramukai S, Mikami Y, Ogawa O, Kamba T.
Int J Clin Oncol. 2015 Dec;20(6):1161-70. doi: 10.1007/s10147-015-0840-5.

Evaluation of prognostic factors after radical prostatectomy in pT3b prostate cancer patients in Japanese population.

Inoue T, Kinoshita H, Terada N, Kobayashi T, Yamasaki T, Matsui Y, Kamba T, Inui H, Sugi M, Matsuda T, Ogawa O.
Jpn J Clin Oncol. 2015 Aug;45(8):780-4. doi: 10.1093/jjco/hyv077.

[Pelvic lymph node dissection in robot-assisted laparoscopic radical prostatectomy: safety and adequacy in introductory series].

Sunada T, Kobayashi T, Shibasaki N, Okada Y, Negoro H, Terada N, Yamasaki T, Matsui Y, Inoue T, Kamba T, Ogawa O.
Hinyokika Kiyo. 2015 Mar;61(3):89-93. Japanese.

Laser-capture microdissection for analysis of cell type-specific gene expression of muscarinic receptor subtypes in the rat bladder with cyclophosphamide-induced cystitis.

Sugino Y, O'Malley KJ, Wang Z, Tyagi P, Birder LA, Ogawa O, Yoshimura N.
Int Urol Nephrol. 2015 Apr;47(4):637-42. doi: 10.1007/s11255-015-0926-z.

Expression of parathyroid hormone/parathyroid hormone-related peptide receptor 1 in normal and diseased bladder detrusor muscles: a clinico-pathological study.

Nishikawa N, Yago R, Yamazaki Y, Negoro H, Suzuki M, Imamura M, Toda Y, Tanabe K, Ogawa O, Kanematsu A.
BMC Urol. 2015 Jan 21;15:2. doi: 10.1186/1471-2490-15-2.

Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO/ICUD consensus.

Schmitz-Drager BJ, Droller M, Lokeshwar VB, Lotan Y, Hudson MA, van Rhijn BW, Marberger MJ, Fradet Y, Hemstreet GP, Malmstrom PU, Ogawa O, Karakiewicz PI, Shariat SF.
Urol Int. 2015;94(1):1-24. doi: 10.1159/000369357. Review.

MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway.

Sun D, Sawada A, Nakashima M, Kobayashi T, Ogawa O, Matsui Y.
Urol Oncol. 2015 Mar;33(3):111.e17-26. doi: 10.1016/j.urolonc.2014.10.018.

The NOD/Shi-scid/IL-2Rγ(null) mice xenograft model recapitulates anaplastic large cell lymphoma dissemination to the bladder.

Daifu T, Umeda K, Kouzuki K, Hamabata T, Noudomi S, Saida S, Kato I, Hiramatsu H, Watanabe K, Terada N, Imamura M, Ogawa O, Heike T, Adachi S.
Leuk Lymphoma. 2015 May;56(5):1542-3. doi: 10.3109/10428194.2014.966244. No abstract available.

Effects of functional genetic polymorphisms in the CYP19A1 gene on prostate cancer risk and survival.

Kanda S, Tsuchiya N, Narita S, Inoue T, Huang M, Chiba S, Akihama S, Saito M, Numakura K, Tsuruta H, Satoh S, Saito S, Ohyama C, Arai Y, Ogawa O, Habuchi T.
Int J Cancer. 2015 Jan 1;136(1):74-82. doi: 10.1002/ijc.28952.

Discrepancy between local and central pathological review of radical prostatectomy specimens.

Kuroiwa K, Shiraishi T, Ogawa O, Usami M, Hirao Y, Naito S; Clinicopathological Research Group for Localized Prostate Cancer Investigators.
J Urol. 2010 Mar;183(3):952-7. doi: 10.1016/j.juro.2009.11.024.

2014

受賞

齊藤 亮一「2014 Bladder Cancer Advocacy Network Young Investigator Award」受賞

「Consequences of ARID1A Inactivation in Bladder Cancer」

根来 宏光「第21回日本泌尿器科学会学会賞（基礎的研究部門）」受賞

「Involvement of urinary bladder Connexin43 and the circadian clock in coordination of diurnal micturition rhythm. Nature Communications 3:809. 2012」

小林 恭「第31回稲田賞」受賞

「ベースラインPSA値による検診間隔の個別設定は前立腺癌スクリーニングの効率を改善する : 数理モデルを用いた社会経済学的考察」

松本 敬優「第226回関西地方会ベストプレゼンテーション賞」受賞

「精巣腫瘍と前縦隔腫瘍を同時に認め治療方針決定に苦慮した1例」

砂田 拓郎「第227回関西地方会ベストプレゼンテーション賞」受賞

「カルボプラチン（CBDCA)・パクリタキセル（PTX)投与にて長期寛解が得られている内分泌療法(ADT)不応性前立腺癌の1例」

論文・依頼原稿

[Presurgical treatment of axitinib reduced operation risk by downsizing the vena cava tumor thrombus in advanced renal cell carcinomas: two case reports].

Hamada A, Yamasaki T, Negoro H, Kobayashi T, Terada N, Sugino Y, Matsui Y, Inoue T, Kamba T, Yoshimura K, Ogawa O.
Hinyokika Kiyo. 2014 Dec;60(12):621-6. Japanese.

[Development of a preoperative criterion to select candidates for nerve-sparing radical prostatectomy at Kyoto University Hospital].

Mizuno K, Inoue T, Miyazaki Y, Makino Y, Terada N, Kobayashi T, Yamasaki T, Matsui Y, Kamba T, Yoshimura K, Mikami Y, Ogawa O.
Hinyokika Kiyo. 2014 Nov;60(11):543-7. Japanese.

[A case of late perirenal fat recurrence after partial nephrectomy for T1A renal cell carcinoma].

Fukui T, Yamasaki T, Mizuno K, Negoro H, Kobayashi T, Terada N, Sugino Y, Matsui Y, Inoue T, Kamba T, Yoshimura K, Ogawa O.
Hinyokika Kiyo. 2014 Oct;60(10):481-3. Japanese.

The NOD/Shi-scid/IL-2Rγ(null) mice xenograft model recapitulates anaplastic large cell lymphoma dissemination to the bladder.

Daifu T, Umeda K, Kouzuki K, Hamabata T, Noudomi S, Saida S, Kato I, Hiramatsu H, Watanabe KI, Terada N, Imamura M, Ogawa O, Heike T, Adachi S.
Leuk Lymphoma. 2014 Oct 24:1-2.

The C-terminal fragment of prostate-specific antigen, a 2331 Da peptide, as a new urinary pathognomonic biomarker candidate for diagnosing prostate cancer.

Nakayama K, Inoue T, Sekiya S, Terada N, Miyazaki Y, Goto T, Kajihara S, Kawabata S, Iwamoto S, Ikawa K, Oosaga J, Tsuji H, Tanaka K, Ogawa O.
PLoS One. 2014 Sep 18;9(9):e107234. doi: 10.1371/journal.pone.0107234. eCollection 2014.

[Urinary diversion in patients treated with pelvic irradiation: transverse colon conduit revisited].

Matsui Y, Kanematsu A, Negoro H, Kobayashi T, Terada N, Sugino Y, Yamasaki T, Inoue T, Kamba T, Yoshimura K, Ogawa O.
Hinyokika Kiyo. 2014 Aug;60(8):365-70. Japanese.

Up-regulation of miR-582-5p regulates cellular proliferation of prostate cancer cells under androgen-deprived conditions.

Maeno A, Terada N, Uegaki M, Goto T, Okada Y, Kobayashi T, Kamba T, Ogawa O, Inoue T.
Prostate. 2014 Dec;74(16):1604-12. doi: 10.1002/pros.22877. Epub 2014 Aug 29.

[A case of successful living related renal transplantation in a patient with end-stage renal disease resulting from sarcoidosis].

Takeda M, Kobayashi T, Sumiyoshi S, Okubo K, Negoro H, Miyata H, Terada N, Sugino Y, Yamasaki T, Matsui Y, Inoue T, Kamba T, Yoshimura K, Ogawa O.
Hinyokika Kiyo. 2014 Jul;60(7):319-22. Japanese.

Altered detrusor gap junction communications induce storage symptoms in bladder inflammation: a mouse cyclophosphamide-induced model of cystitis.

Okinami T, Imamura M, Nishikawa N, Negoro H, Sugino Y, Yoshimura K, Kanematsu A, Hashitani H, Ogawa O.
PLoS One. 2014 Aug 6;9(8):e104216. doi: 10.1371/journal.pone.0104216. eCollection 2014.

Recent trends in the initial therapy for newly diagnosed prostate cancer in Japan.

Onozawa M, Hinotsu S, Tsukamoto T, Oya M, Ogawa O, Kitamura T, Suzuki K, Naito S, Namiki M, Nishimura K, Hirao Y, Akaza H.
Jpn J Clin Oncol. 2014 Oct;44(10):969-81. doi: 10.1093/jjco/hyu104. Epub 2014 Aug 6.

[Perioperative agranulocytosis induced by immunosuppressants in a renal graft recipient : a case report].

Matsumoto K, Kobayashi T, Murakami K, Okubo K, Negoro H, Terada N, Sugino Y, Yamasaki T, Matsui Y, Inoue T, Kamba T, Yoshimura K, Ogawa O.
Hinyokika Kiyo. 2014 Jun;60(6):275-8. Japanese.

A genome-wide association study of serum levels of prostate-specific antigen in the Japanese population.

Terao C, Terada N, Matsuo K, Kawaguchi T, Yoshimura K, Hayashi N, Shimizu M, Soga N, Takahashi M; Nagahama Cohort Study Group, Kotoura Y, Yamada R, Ogawa O, Matsuda F.
J Med Genet. 2014 Aug;51(8):530-6. doi: 10.1136/jmedgenet-2014-102423. Epub 2014 Jun 11.

[Small cell carcinoma of the bladder].

Sakatani T, Shimizu Y, Sugino Y, Yamasaki T, Imamura M, Matsui Y, Inoue T, Okubo K, Kamba T, Yoshimura K, Ogawa O.
Hinyokika Kiyo. 2014 May;60(5):221-5. Japanese.

The effect of ABCG2 genotype on the population pharmacokinetics of sunitinib in patients with renal cell carcinoma.

Mizuno T, Fukudo M, Fukuda T, Terada T, Dong M, Kamba T, Yamasaki T, Ogawa O, Katsura T, Inui K, Vinks AA, Matsubara K.
Ther Drug Monit. 2014 Jun;36(3):310-6. doi: 10.1097/FTD.0000000000000025.

Antiemetic efficacy and safety of a combination of palonosetron, aprepitant, and dexamethasone in patients with testicular germ cell tumor receiving 5-day cisplatin-based combination chemotherapy.

Hamada S, Hinotsu S, Kawai K, Yamada S, Narita S, Kamba T, Nishiyama H, Arai Y, Habuchi T, Ogawa O, Kawakami K.
Support Care Cancer. 2014 Aug;22(8):2161-6. doi: 10.1007/s00520-014-2182-7. Epub 2014 Mar 21.

The expression profile of phosphatidylinositol in high spatial resolution imaging mass spectrometry as a potential biomarker for prostate cancer.

Goto T, Terada N, Inoue T, Nakayama K, Okada Y, Yoshikawa T, Miyazaki Y, Uegaki M, Sumiyoshi S, Kobayashi T, Kamba T, Yoshimura K, Ogawa O.
PLoS One. 2014 Feb 28;9(2):e90242. doi: 10.1371/journal.pone.0090242. eCollection 2014.

Novel constant-pressure irrigation technique for the treatment of renal pelvic tumors after ipsilateral ureterectomy.

Nakamura K, Terada N, Sugino Y, Yamasaki T, Matsui Y, Imamura M, Okubo K, Kamba T, Yoshimura K, Ogawa O.
Int J Urol. 2014 Jun;21(6):617-8. doi: 10.1111/iju.12386. Epub 2014 Jan 9.

Long-term outcomes of dynamic conformal arc irradiation combined with neoadjuvant hormonal therapy in Japanese patients with T1c-T2N0M0 prostate cancer: case series study.

Ikeda I, Mizowaki T, Norihisa Y, Takayama K, Kamba T, Inoue T, Nakamura E, Kamoto T, Ogawa O, Hiraoka M.
Jpn J Clin Oncol. 2014 Feb;44(2):180-5. doi: 10.1093/jjco/hyt197. Epub 2013 Dec 29.

Exposure-toxicity relationship of sorafenib in Japanese patients with renal cell carcinoma and hepatocellular carcinoma.

Fukudo M, Ito T, Mizuno T, Shinsako K, Hatano E, Uemoto S, Kamba T, Yamasaki T, Ogawa O, Seno H, Chiba T, Matsubara K.
Clin Pharmacokinet. 2014 Feb;53(2):185-96. doi: 10.1007/s40262-013-0108-z.

Improvement of prognosis in patients with metastatic renal cell carcinoma and Memorial Sloan-Kettering Cancer Center intermediate risk features by modern strategy including molecular-targeted therapy in clinical practice.

Kamba T, Yamasaki T, Teramukai S, Shibasaki N, Arakaki R, Sakamoto H, Matsui Y, Okubo K, Yoshimura K, Ogawa O.
Int J Clin Oncol. 2014 Jun;19(3):505-15. doi: 10.1007/s10147-013-0581-2. Epub 2013 Jun 28.